A Combined Molecular, Cell and Structural Biology Approach Towards Characterising Malaria Alveolins by Coghlan, MP
LSHTM Research Online
Coghlan, MP; (2020) A Combined Molecular, Cell and Structural Biology Approach Towards Char-





Please refer to usage guidelines at https://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.








A	  Combined	  Molecular,	  Cell	  and	  Structural	  Biology	  Approach	  Towards	  
Characterising	  Malaria	  Alveolins	  
	  
Michael	  Patrick	  Coghlan	  
	  
	  
Thesis	  submitted	  in	  accordance	  with	  the	  requirements	  for	  the	  degree	  of	  
Doctor	  of	  Philosophy	  
	  
University	  of	  London	  
2020	  
	  
	  	  	  	  	  Department	  of	  Infection	  Biology	  
	  
	  	  	  	  	  	  	  	  	  	  Faculty	  of	  Infectious	  Tropical	  Diseases	  
	  
LONDON	  SCHOOL	  OF	  HYGIENE	  &	  TROPICAL	  MEDICINE	  
	  
	  
Funded	  by	  the	  BBSRC	  
	  
Research	  supervisors:	  
Dr.	  Johannes	  Dessens	  














Without	   a	   doubt,	  my	   greatest	   thanks,	   deepest	   appreciation	   and	  boundless	   gratitude	  
goes	  to	  my	  primary	  supervisor,	  boss,	  scientist-­‐in-­‐chief,	  Hans.	  Without	  your	  support	  and	  
guidance,	  I	  genuinely	  would	  not	  have	  made	  it	  this	  far.	  A	  mentor,	  friend,	  colleague	  and	  
supervisor	   all	   in	   one,	   you	   have	   kept	   me	   motivated	   during	   times	   when	   all	   seemed	  
hopeless.	   Thank	   you	   for	   not	   giving	   up	   on	  me.	   If	   I	   become	   even	   half	   the	   competent	  
scientist	  as	  you,	  I	  know	  I	  will	  have	  made	  it.	  It	  has	  been	  an	  honour	  and	  my	  privilege	  to	  
have	  undertaken	  my	  doctoral	  training	   in	  the	  Dessens	   laboratory.	   It	  truly	   is	  a	  rarity	  to	  
find	  such	  a	  solid	   lab	  group	  and	  supervisor	  to	  work	  with.	   It	   is	  thanks	  to	  you	  I	  will	   look	  
back	   fondly	   on	  my	   time	   here,	   despite	   the	   terrible	   lab	   book	   keeping	   and	   number	   of	  
errors	  I	  made	  along	  the	  way!	  
	  
My	   secondary	   supervisor,	   Cara,	   has	   shown	  nothing	  but	   kindness	   and	  enthusiasm	   for	  
my	   project,	   and	  welcomed	  me	  with	   open	   arms	   in	   to	   her	   laboratory	   and	   her	   group,	  
training	  me	  in	  the	  world	  of	  structural	  biology	  and	  managing	  to	  make	  me	  feel	   like	  my	  
fumbling	  around	  in	  the	  laboratory	  was	  never	  a	  hassle.	  Thank	  you	  for	  agreeing	  to	  take	  
me	  under	   your	  wing.	   The	  Vaughan	   group	   and	  Rayne-­‐Wolfson	   laboratory,	   have	   been	  
imperative	   in	  ensuring	  that	   I	  did	  not	   lose	  my	  wit	  amongst	   the	  many	  preps	  and	  ÄKTA	  
runs,	  so	  my	  thanks	  goes	  out	  to	  all	  members	  of	  the	  ISMB	  that	  have	  been	  a	  part	  of	  my	  
experience.	   Special	   thanks	   goes	   to	   Dr	   Shomon	  Miah,	   a	   fellow	   LIDo	   student,	   whose	  
friendship,	  guidance	  and	  expertise	  in	  structural	  biology	  is	  truly	  commendable.	  	  
	  
Dr.	  Sadia	  Saeed,	  my	  greatest	  friend	  and	  biggest	  supporter	  throughout	  my	  entire	  time	  
in	   the	   Dessens	   laboratory.	   Thank	   you	   for	   accompanying	   me	   along	   my	   journey	   and	  
allowing	  me	  to	  do	  the	  same	  for	  you.	  Our	  friendship	  was	  key	  in	  making	  me	  feel	  settled	  
in	   the	   laboratory	   and	   thank	   you	   for	   showing	  me	   that	   you	   can	   be	   a	   stellar	   scientist	  
whilst	  life	  happens	  around	  it.	  Thank	  you	  for	  being	  an	  incredible	  mentor,	  for	  welcoming	  
me	  in	  to	  your	  culture	  and	  enlightening	  me	  as	  to	  where	  my	  very	  distant	  cousins	  ended	  
up	   in	  Kalash!	  Sarim	  and	  Ammar	  are	   incredibly	   lucky	  to	  have	  such	  a	  strong	  woman	  as	  
their	  mother.	  I	  know	  I	  have	  found	  a	  friend	  for	  life	  in	  you.	  	  
	  
Dr.	  Annie	  Tremp,	  an	  embodiment	  of	  what	  an	  excellent	  scientist	  is.	  Not	  only	  managing	  a	  
successful	  career	  alongside	  a	  busy	  family	  life,	  you	  have	  shown	  endless	  compassion	  and	  
a	  willingness	   to	   share	   your	   knowledge	  with	  me	   along	  my	   journey	   in	   completing	  my	  
PhD,	  whilst	  offering	  constant	  reassurance	  when	  I	  felt	  things	  were	  going	  terribly	  wrong.	  
It	  must	  not	  be	  easy	   coming	  back	   to	  work	   after	  maternity	   leave	  and	   settling	  back	   in;	  
however,	   you	   did	   so	   seamlessly,	   and	   are	   a	   remarkable	   example	   of	   how	   strong	   a	  
woman	  and	  mother	  you	  are	  to	  Lucas	  and	  Alex.	  	  
	  
To	  Nadine	  Mogford,	  a	  friend	  and	  shoulder	  to	  cry	  on,	  you	  have	  been	  a	  rock	  throughout	  




believing	  in	  me	  enough	  to	  join	  the	  LIDo	  programme	  and	  for	  bestowing	  on	  to	  me	  your	  
awesomeness	  and	  guidance	  amongst	  the	  many	  places	  it	  was	  (and	  will	  be!)	  needed.	  	  
	  
Dr.	  Sam	  Alsford,	  thank	  you	  for	  showing	  an	  unwavering	  interest	  in	  my	  project,	  and	  for	  
offering	  constant	  reassurance	  at	  any	  given	  point	  without	  making	  me	  feel	   like	   I	  was	  a	  
bother.	  As	  part	  of	  my	  interview	  panel	  back	  in	  2015,	  I	  thank	  you	  for	  seeing	  in	  me	  what	  I	  
failed	  to	  see	  in	  myself,	  and	  for	  giving	  me	  the	  opportunity	  to	  cease	  my	  dream.	  	  
	  
My	  soon	   to	  be	   fellow	  Dr’s	  Suzy,	  Suvi	  and	  Caroline,	   forever	  bonded	   together	   through	  
the	   combined	   traumas	   of	   our	   PhDs	   and	   the	   comradery	   of	   LIDo,	   with	   a	   few	   broken	  
bones	  along	   the	  way.	   I	   could	  not	  have	  made	  better	   friends	   to	  complete	   this	   journey	  
with.	  	  
	  
To	  my	  mum	   and	   dad,	   Greetz	   and	   Jim,	   thank	   you.	   For	   everything.	   For	   your	   support,	  
endless	  belief	  in	  me,	  and	  everything	  in	  between.	  Despite	  not	  having	  a	  clue	  as	  to	  what	  I	  
am	  doing,	  and	  dads	  incessant	  asking	  of	  ‘have	  you	  found	  a	  cure	  yet’,	  I	  hope	  this	  makes	  
you	  proud.	  To	  my	  Grandma	  Ettie,	  thank	  you	  for	  never	  growing	  bored	  of	  my	  work	  and	  
always	  looking	  forward	  to	  hearing	  about	  it.	  Martina,	  Grandad,	  Nana	  and	  Big	  Michael,	  
thank	  you	  for	  looking	  out	  for	  me	  forever	  and	  always	  from	  beyond	  the	  realms	  of	  time	  
and	  space,	  I	  could	  not	  have	  done	  it	  without	  you.	  	  
	  
To	  other	  friends	  and	  family	  too	  endless	  to	  mention,	  thank	  you	  for	  putting	  up	  with	  me	  
throughout	  these	  past	  four	  years,	  and	  for	  not	  questioning	  my	  sanity	  too	  harshly	  along	  
the	  way.	  Aisha,	  Hanwell,	  Loredana	  and	  Sarah	  will	  always	  have	  a	  piece	  of	  my	  heart.	  	  
	  
And	  to	  everyone	  who	  thought	  all	  I	  did	  was	  ‘feed	  mosquitos	  at	  the	  university	  of	  tropical	  









Coghlan,	  M.P.,	  Tremp,	  A.Z.,	  Saeed,	  S.,	  Vaughan,	  C.K.,	  Dessens,	  J.T.	  	  
Distinct	  Functional	  Contributions	  by	  the	  Conserved	  Domains	  of	  the	  Malaria	  Parasite	  
Alveolin	  IMC1h.	  	  








I	  have	  read	  and	  understood	  the	  LSHTM’s	  definition	  of	  plagiarism	  and	  cheating.	   I	  declare	  that	  
this	  thesis	  is	  my	  own	  work,	  and	  that	  I	  have	  acknowledged	  all	  results	  and	  quotations	  from	  the	  
published	  or	  unpublished	  work	  of	  other	  people.	  
	  
I	   have	   read	   and	   understood	   the	   LSHTM’s	   definition	   and	   policy	   on	   the	   use	   of	   third	   parties	  
(either	   paid	   or	   unpaid)	  who	   have	   contributed	   to	   the	   preparation	   of	   this	   thesis	   by	   providing	  
copy	   editing	   and,	   or,	   proof	   reading	   services.	   	   I	   declare	   that	   no	   changes	   to	   the	   intellectual	  
content	  or	  substance	  of	  this	  thesis	  were	  made	  as	  a	  result	  of	  this	  advice,	  and,	  that	  I	  have	  fully	  
acknowledged	  all	  such	  contributions.	  
	  
I	  have	  exercised	  reasonable	  care	  to	  ensure	  that	  the	  work	  is	  original	  and	  does	  not	  to	  the	  best	  of	  















Student	  signature	   	  








Intermediate	   filament	   (IF)-­‐based	   cytoskeletal	   networks	   in	   metazoans	   have	   key	   roles	   in	   cell	  
architecture	  and	  plasticity,	  and	  as	  mechanical	  stress	  absorbers.	  Much	  less	  is	  known	  about	  IFs	  in	  
protozoans.	   Alveolins	   are	   a	   family	   of	   putative	   IF	   proteins	   found	   exclusively	   in	   apicomplexan	  
parasites	   (causative	   agents	   of	   diseases	   such	   as	   malaria,	   toxoplasmosis,	   cryptosporidiosis),	  
dinoflagellate	  algae	  and	  ciliates.	  All	  alveolins	  share	  functional	  domains	  that	  are	  characterized	  
by	   possessing	   12	   amino-­‐acid	   tandem	   repeats.	   These	   ‘alveolin’	  modules	   resemble	   conserved	  
domains	   found	   in	   other	   protozoan	   cytoskeletal	   proteins	   like	   articulins.	   The	   demonstrated	  
essential	  nature	  of	  alveolins	  in	  malaria	  parasite	  development,	  their	  expression	  throughout	  the	  
life	  cycle,	  and	  their	  absence	  in	  vertebrates	  makes	  them	  potentially	  attractive	  drug	  targets	  for	  
malaria	  treatment,	  prophylaxis	  and	  transmission	  control.	  Moreover,	  such	  drugs	  could	  be	  active	  
against	  a	  broad	  range	  of	  other	  apicomplexan	  parasites,	  as	  well	  as	  against	  related	  pathogenic	  
protozoans.	  In	  this	  context,	  a	  better	  understanding	  of	  the	  core	  architecture	  of	  the	  Plasmodium	  
alveolins	  and	  their	  assembly	  mechanisms	  is	  important.	  	  
This	  project	  set	  out	  to	  study	  the	  structural	  requirements	  of	  the	  alveolins	  and	  their	  conserved	  
domains	  for	  assembly	  of	  the	  protein	  into	  the	  IF	  network,	  and	  for	  their	  functional	  contribution	  
to	   cell	   shape,	   tensile	   strength	   and	   motility	   in	   live	   malaria	   parasites,	   using	   the	   Plasmodium	  
berghei	   mouse	   malaria	   model.	   The	   results	   reveal,	   based	   on	   the	   ookinete	   and	   sporozoite-­‐
expressed	   alveolin	   IMC1h,	   that	   the	   ‘alveolin’	   module	   is	   required	   for	   recruitment	   into	   the	  
cortical	  cytoskeleton,	  consistent	  with	  the	  notion	  that	  it	  holds	  the	  properties	  for	  IF	  formation.	  In	  
addition,	   the	   carboxy-­‐terminal	   conserved	   domain	   of	   IMC1h,	   structurally	   unrelated	   to	   the	  
‘alveolin’	   module,	   is	   implicated	   in	   facilitating	   parasite	   motility	   through	   direct	   or	   indirect	  
interactions	  with	  the	  motility	  apparatus.	  
In	   addition,	   a	   structural	   biology	   approach	   was	   undertaken,	   aimed	   at	   determining	   the	   core	  
atomic	  structure	  of	  the	  alveolins,	  with	  various	  techniques	  at	  hand	  to	  try	  and	  determine	  both	  
tertiary	   and	   secondary	   structures	   formed	   by	   these	   proteins.	   Bioinformatic-­‐based	   analyses	  
indicated	   that	   the	   ‘alveolin’	   module	   is	   structurally	   ordered,	   and	   adopts	   a	   predominantly	   β-­‐
strand	   architecture.	   High	   level	   expression,	   in	   soluble	   form,	   of	   various	   P.	   berghei	   alveolin	  
domains	   in	   bacteria	   was	   achieved	   as	   amino-­‐terminal	   fusions	   with	   the	   protein	   tag	   NusA.	  
However,	   further	   purification	   of	   these	   recombinant	   alveolins	   was	   severely	   hampered	   by	  
problems	  with	   solubility	   after	   cleavage	   of	   the	   NusA	   tag,	   or	   after	   concentration,	   resulting	   in	  
protein	   precipitation.	  Whilst	   these	   problems	   have	   thus	   far	   precluded	   structural	   analyses	   by	  
biophysical	  means,	   the	   observations	   could	   reflect	   actual	   physical	   properties	   of	   the	   alveolins	  
and	   the	   way	   by	   which	   these	   molecules	   assemble	   in	   the	   cell	   into	   the	   insoluble	   IF	   network	  
structure,	  possibly	  via	  the	  intermittent	  formation	  of	  shorter	  oligomers	  (protofilaments).	  Work	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Malaria	   remains	   one	   of	   the	   most	   devastating	   parasitic	   diseases	   affecting	   the	   globe	  
today.	  The	  estimated	  number	  of	  incidences	  of	  malaria	  in	  2018	  was	  228	  million,	  causing	  
an	  estimated	  405,000	  deaths.	  Ten	  countries	   in	  sub-­‐Saharan	  Africa	  and	  India	  together	  
make	  up	  the	  large	  majority	  of	  malaria	  cases	  worldwide,	  while	  malaria	  cases	  are	  on	  the	  
rise	   in	   the	   Americas,	   despite	   spending	   over	   US$	   2.7	   billion	   globally	   on	   fighting	   the	  
disease	  in	  2018	  (WHO	  Malaria	  Report,	  2019).	  
The	   disease	  malaria	   is	   caused	   by	   the	   apicomplexan	   protozoan	   parasite	  Plasmodium,	  
part	   of	   the	   phylum	  Apicomplexa.	   Apicomplexan	   organisms	   comprise	   of	   a	   number	   of	  
significant	   parasites	   that	   burden	   both	   vertebrate	   and	   invertebrate	   species,	   including	  
Toxoplasma	   and	   Cryptosporidium,	   causing	   toxoplasmosis	   and	   cryptosporidiosis	  
respectively.	  Apicomplexans	  all	  have	  complex	  life	  cycles	  and	  present	  a	  wide	  variety	  of	  
morphologically	   distinct	   shapes	   depending	   on	   genus	   and	   stage.	   Key	   morphological	  
features	   of	   Apicomplexan	   parasites	   include	   the	   presence	   of	   an	   ‘apical	   complex’,	  
containing	   polar	   rings	   and	   specialized	   secretory	   organelles	   such	   as	   rhoptries	   and	  
micronemes,	  which	  are	  located	  at	  the	  anterior	  end	  of	  the	  infective	  life	  stages,	  as	  well	  
as	  a	  unique	  cortical	   cytoskeletal	   structure	  known	  as	   the	  pellicle	   (Gould	  et	  al.,	   2008).	  
The	  Apicomplexa	   are	  part	   of	   the	   superphylum	  Alveolata,	  which	   also	   includes	   ciliates	  
and	  dinoflagellates.	  Alveolates	  are	   characterized	  by	  possessing	  a	   system	  of	  adjoining	  
cytoskeletal	  components	  underneath	  the	  plasma	  membrane,	  known	  as	  alveoli,	  and	  the	  
pellicle	  is	  the	  equivalent	  structure	  in	  Plasmodium	  (Gould	  et	  al.,	  2008).	  	  
Of	  the	  more	  than	  100	  identified	  species	  of	  malaria,	  five	  are	  known	  to	  infect	  humans.	  




malariae	  and	  the	  newly	  emerging	  human	  pathogen	  of	  interest	  P.	  knowlesi	  (Kantele	  and	  
Jokiranta,	  2011,	  Calderaro	  et	  al.,	  2013,	  Fuehrer	  and	  Noedl,	  2014).	  Each	  species	  affects	  
different	  areas	  of	  the	  globe	  and	  have	  different	  prevalence’s	  in	  each	  area.	  P.	  falciparum	  
is	  found	  predominantly	  in	  Africa	  and	  has	  the	  largest	  number	  of	  deaths	  associated	  with	  
its	   infection.	  There	  are	   few	  antimalarial	  drugs	  available	   to	   treat	   the	  disease,	  and	   the	  
increase	   in	  antimalarial	  drug	   resistance,	   including	  against	   the	  most	  widely	  used	  drug	  
artemisinin,	  is	  cause	  for	  concern	  (Amato	  et	  al.,	  2018,	  Rosenthal,	  2018,	  Uhlemann	  and	  
Krishna,	  2005).	  This	  emphasizes	  the	  need	  to	  increase	  our	  understanding	  of	  the	  parasite	  
and	  therefore	  novel	  strategies	  for	  its	  control.	  	  
1.1.2	  The	  Plasmodium	  life	  cycle	  
Plasmodium	   species	   have	   a	   complex	   life	   cycle	   involving	   different	   hosts,	   both	   the	  
definitive	  host	  Anopheles	  spp	  and	  the	  intermediate	  vertebrate	  host	  (Aly	  et	  al.,	  2009).	  It	  
involves	   different	   life	   stages	   with	   distinct	   morphological	   features,	   characteristic	   of	  
apicomplexan	  parasites.	  A	  newly	  acquired	  infection	  will	  begin	  when	  a	  parasite-­‐infected	  
mosquito	   injects	   infective	  sporozoites	  during	  a	  mosquito	  bite	   (Fig.	  1.1A).	  Sporozoites	  
migrate	   to	   the	   liver	   through	   the	  blood,	  where	   they	   infect	  hepatocytes	   (Prudencio	  et	  
al.,	   2006).	   Here,	   they	   develop	   in	   to	   a	   hepatic	   schizont,	   undergoing	   nuclear	   division	  
known	   as	   schizogony	   (Cowman	   and	   Crabb,	   2006).	   Each	   mature	   liver	   schizont	   can	  
contain	  thousands	  of	  merozoites	  that	  are	  subsequently	  released	  in	  to	  the	  blood	  stream	  
(Fig.	  1.1B).	  These	  merozoites	  then	  invade	  red	  blood	  cells	  and	  enter	  the	  erythrocytic	  life	  
stage	   (Fig.	   1.1C).	   Once	   red	   blood	   cell	   (RBC)	   invasion	   has	   occurred,	   the	   merozoite	  
develops	   in	   to	   a	   schizont	   which	   ruptures,	   releasing	   8-­‐32	   merozoites	   (depending	   on	  




invasion.	   	   These	   asexual	   life	   cycle	   stages	   of	   the	   parasite	   are	   haploid	   (Cowman	   and	  
Crabb,	  2006).	  
In	  order	  for	  the	  parasite	  to	  complete	  its	  life	  cycle,	  during	  the	  asexual	  life	  stage,	  a	  small	  
number	  of	  reinvading	  merozoites	  will	  develop	  in	  to	  sexual	  stage	  precursor	  cells	  named	  
gametocytes	   in	   a	   process	   known	   as	   gametocytogenesis	   (Fig.	   1.1D).	   At	   this	   point,	   an	  
Anopheles	  mosquito	   is	   required	   to	   blood	   feed	   on	   the	   already	   infected	   intermediate	  
host	   and	   ingest	   the	   female	   and	  male	   gametocytes.	  After	   entering	   the	  midgut	  of	   the	  
mosquito,	  rapid	  division	  and	  egress	  of	  male	  gametocytes	  (microgametes)	  and	  escape	  
of	  female	  gametocytes	  (macrogametes)	  from	  RBCs	  occurs	  due	  to	  environmental	  cues,	  
in	   a	   process	   known	   as	   gametogenesis	   (Delves	   et	   al.,	   2013).	   There	   are	   several	  
contributing	   factors	   to	   gametogenesis,	   however	   major	   cues	   include	   a	   drop	   in	  
temperature,	  a	  rise	  in	  pH,	  and	  xanthurenic	  acid,	  also	  known	  as	  gametocyte	  activating	  
factor	  (Arai	  et	  al.,	  2001).	  Each	  male	  gametocyte	  will	  produce	  eight	  microgametes,	  and	  
a	  female	  gametocyte	  will	  produce	  a	  single	  macrogamete.	  The	  microgametes	  are	  motile	  
and	   forcefully	   beat	   their	   flagella	   when	   leaving	   the	   RBC	   in	   a	   process	   known	   as	  
exflagellation,	   facilitating	   their	   aim	   to	   penetrate	   a	   macrogamete	   (Fig.	   1.1E).	   Once	  
penetration	  and	  fertilisation	  occurs,	  the	  zygote	  develops	  in	  to	  a	  motile	  ookinete	  that	  is	  
able	   to	   invade	   the	  midgut	   epithelium	   (Fig.	   1.1F).	  On	   the	   basal	   lamina	   of	   the	  midgut	  
wall,	  the	  ookinete	  transforms	  in	  to	  the	  oocyst.	  Over	  a	  period	  of	  1-­‐3	  weeks,	  the	  oocyst	  
grows	  in	  size	  with	  multiple	  rounds	  of	  endomitosis.	  A	  final	  cytokinesis	  step	  culminates	  
in	   the	   formation	   of	   hundreds	   of	   sporozoites	   which	   are	   released	   from	   the	   oocyst,	  
allowing	  them	  to	  invade	  the	  salivary	  glands	  (Fig.	  1.1G).	  Here,	  they	  lie	  dormant	  waiting	  





Fig	  1.1	  The	  malaria	  life	  cycle.	  The	  Anopheles	  mosquito	  bites	  and	  infects	  a	  human	  with	  sporozoites	  (A).	  Sporozoites	  
then	  migrate	  to	  the	  liver	  where	  they	  pass	  through	  numerous	  hepatocytes	  before	  forming	  a	  liver	  schizont,	  releasing	  
merozoites	  (B).	  Merozoites	  invade	  RBCs	  and	  grow	  in	  to	  trophozoites	  and	  schizonts,	  rupturing	  and	  repeating	  the	  
cycle	  (C).	  Gametocytes	  are	  taken	  up	  by	  a	  feeding	  mosquito,	  causing	  gametogenesis	  (E).	  Upon	  fertilisation,	  the	  
zygote	  grows	  in	  to	  an	  ookinete	  (F),	  and	  then	  an	  oocyst,	  releasing	  sporozoites	  that	  can	  invade	  the	  salivary	  gland	  (G).	  
Adapted	  from	  (Cowman	  et	  al.,	  2012).	  
	  
1.1.3	  The	  ‘zoite’	  stages	  
Plasmodium	  spp.	  have	  three	  motile	  and	  invasive	  life	  stages	  (also	  known	  as	  ‘zoites’):	  the	  
merozoite,	   the	   ookinete	   and	   the	   sporozoite	   (Fig	   1.2).	   Despite	   their	   distinct	   sizes,	  
shapes	  and	  host	  cell	  specificities,	  these	  zoites	  have	  common	  cellular	  architectures	  that	  
facilitate	  motility,	   invasion	  and	  egress:	  the	  apical	  complex	  and	  the	  pellicle.	  The	  apical	  
complex	   is	   responsible	   for	   aiding	   the	   zoite	   in	   interacting	   with	   the	   host	   cell	   and	   its	  
invasion.	  The	  pellicle	  assists	  with	  the	  parasites	  gliding	  motility,	  a	  substrate-­‐dependent	  
movement	   that	   is	   essential	   for	   motion	   in	   and	   around	   the	   host	   environment.	   	   This	  




conserved	   between	   apicomplexan	   parasites.	   This	   actomyosin	   network	   is	   located	  
beneath	   the	   plasma	  membrane	   and	   is	   anchored	   into	   the	   inner	  membrane	   complex.	  
Each	   invasive	   life	   stage	   of	   the	   parasite	   is	   specialised	   to	   invade	   different	   host	   cells	  
(Sinnis	  and	  Coppi,	  2007,	  Siden-­‐Kiamos	  et	  al.,	  2006).	  	  
	  
Fig	  1.2	  An	  ultrastructural	  summary	  of	  the	  invasive	  life	  stages	  of	  Plasmodium	  species.	  The	  ookinete,	  the	  merozoites	  
and	   the	   sporozoite,	   with	   arrowed	  movements	   showing	   the	   direction	   and	   rotation	   of	   movement.	   Labels	   for	   the	  
diagram	  include:	  Rh:	  rhoptries.	  Mn:	  micronemes.	  N:	  nucleus.	  Nu:	  nucleolus.	  M(1,2):	  mitochondrion.	  Mn:	  microneme.	  
OM:	  Outer	  membrane.	   IM:	   Inner	  membrane.	  AR:	  apical	   ring.	  SPMt:	  Subpellicular	  microtubules.	  1µm	  scale	  bar	   for	  





1.1.4	  The	  merozoite	  
The	  merozoite	  is	  the	  invasive	  life	  stage	  of	  the	  parasite	  that	  infects	  RBCs	  during	  asexual	  
reproduction.	   Once	   an	   infection	   is	   established	   in	   hepatocytes	   and	   undergoes	  
exoerythrocytic	   schizogony,	   merozoites	   are	   released	   in	   to	   the	   blood	   stream	   where	  
they	  can	  invade	  and	  replicate	  within	  RBCs.	  During	  the	  brief	  extracellular	  movement	  of	  
the	  merozoite	  before	   invading	  new	  RBCs,	   the	  merozoites	  are	  exposed	  to	  host	   innate	  
and	   adaptive	   immune	   responses	   (Guevara	   Patino	   et	   al.,	   1997).	   The	   immune	   system	  
may	  prevent	  a	  small	  number	  of	  merozoites	  from	  establishing	  an	  infection,	  however	  the	  
high	   number	   of	   merozoites	   released	   from	   initial	   liver	   schizogony	   allows	   enough	  
merozoites	   to	   reliably	   establish	   a	   host	   infection	   (Garnham,	   1951,	   Belachew,	   2018).	  
Erythrocytic	   schizogony	   releases	   fewer	   merozoites	   than	   exoerythrocytic	   schizogony	  
and	   shows	   no	   enlargement	   of	   RBCs	   upon	   infection,	   with	   up	   to	   32	   merozoites	  
depending	   on	   the	   Plasmodium	   species	   (Antinori	   et	   al.,	   2012).	   The	   apical	   complex	  
contributes	   to	   RBC	   invasion.	   After	   an	   interaction	   and	   attachment	   is	   established,	   the	  
merozoite	   is	   able	   to	   reorientate	   itself	   so	   that	   the	   apical	   end	   of	   the	   parasite	  makes	  
contact	  with	   the	   RBC.	   On	   invasion	   of	   the	   RBC,	   a	   parasitophorous	   vacuole	   is	   formed	  
from	  which	  the	  parasite	  resides,	  growing	  and	  replicating	  to	  form	  a	  schizont,	  leading	  to	  
release	   of	  more	  merozoites.	   On	   invasion,	   the	  merozoites	   thick	   coat,	   formed	   of	   thin	  
filaments	  used	  for	  attachment,	  are	  cleaved	  from	  it	  (Bannister	  et	  al.,	  1986).	  There	  are	  a	  
number	   of	   secretory	   organelles	   located	   in	   the	   apical	   complex	   that	   assist	   the	   entire	  
process.	   These	   are:	   (1)	   micronemes,	   involved	   in	   gliding	   motility	   attachment	   and	  
invasion;	  (2)	  rhoptries,	  involved	  in	  attachment,	  invasion,	  and	  the	  establishment	  of	  the	  
parasitophorous	  vacuole;	  (3)	  dense	  granules	  for	  aiding	  in	  forming	  the	  parasitophorous	  
vacuole,	   and	   (4)	   exonemes,	   involved	   in	   merozoite	   egress	   from	   an	   infected	   RBC	  




1.1.5	  The	  ookinete	  
The	  ookinete	   is	   involved	   in	  host	  cell	   invasion	  and	  movement	   in	   the	  mosquito	  vector.	  
Plasmodium	   infection	  of	  the	  vector	  constitutes	  a	  major	  population	  bottleneck	  for	  the	  
parasite	   (Alavi	   et	   al.,	   2003),	   and	   is	   therefore	   an	   attractive	   target	   for	   transmission	  
prevention	  strategies.	  By	  preventing	  the	  development	  of	  the	  parasite	  in	  the	  Anopheles	  
midgut,	  the	  vector	  will	  no	  longer	  be	  able	  to	  transmit	  the	  parasite	  to	  the	  human	  hosts.	  
Upon	   fertilization,	   key	   changes	   take	   place	   during	   the	   differentiation	   of	   the	   spherical	  
zygote	   into	   the	  elongated	  ookinete.	   Surface	  proteins	  on	   the	  parasite	  are	   changed	   to	  
aid	  the	  ookinete	  in	  interacting	  with	  the	  mosquito	  environment,	  most	  notably	  P25	  and	  
P28	   (Tomas	   et	   al.,	   2001).	   The	   apical	   complex	   and	   pellicle	   form,	   and	   the	   zygote	  
undergoes	   DNA	   replication,	   followed	   by	   meiotic	   division,	   resulting	   in	   a	   tetraploid	  
nucleus	  with	  four	  haploid	  genomes	  (Sinden	  et	  al.,	  1985).	  Once	  the	  mature	  ookinete	  is	  
formed,	  it	  must	  escape	  the	  protease-­‐rich	  midgut	  lumen	  before	  it	   is	  digested	  with	  the	  
blood	  meal	  (Billingsley,	  1990).	  The	  ookinete	  must	  penetrate	  the	  peritrophic	  matrix	  that	  
envelops	  the	  blood	  meal,	  which	  is	  aided	  by	  the	  release	  of	  chitinases	  that	  break	  down	  
this	  chitinous	  structure	  (Shahabuddin	  et	  al.,	  1993).	  The	  ookinete	  must	  then	  invade	  and	  
traverse	   cells	   in	   the	   midgut	   epithelium	   to	   reach	   the	   basal	   lamina,	   where	  
transformation	  into	  the	  oocyst	  takes	  place.	  
1.1.6	  The	  sporozoite	  
At	   the	   basal	   lamina,	   the	   oocyst	   grows	   and	   undergoes	  multiple	   steps	   of	  mitosis	   and	  
replication	   of	   organelles	   within	   a	   short	   space	   of	   time	   to	   form	   up	   to	   thousands	   of	  
sporozoites	   (Rosenberg	   and	   Rungsiwongse,	   1991).	   Cytokinesis	   begins	   with	   the	  
invagination	   of	   oocyst	   cytoplasm	   forming	   sporoblasts.	   These	   sporoblasts	   then	   form	  




concomitant	  with	  pellicle	  formation	  (Matuschewski,	  2006).	  As	  the	  budding	  sporozoite	  
elongates,	  a	  haploid	  nucleus	  moves	   into	   it	   along	  with	  mitochondrion	  and	  apicoplast.	  
Micronemes	  and	  rhoptries	  are	  formed	  at	  the	  apical	  region	  of	  the	  emerged	  sporozoite.	  
Sporozoites	   become	   flexible	   and	   motile	   after	   their	   release	   from	   the	   sporoblast.	   On	  
rupture	  of	  the	  oocyst,	  sporozoites	  are	  released	  into	  the	  haemolymph	  of	  the	  mosquito	  
and	   migrate	   to	   the	   salivary	   glands	   of	   the	   insect	   (Smith	   and	   Jacobs-­‐Lorena,	   2010,	  
Matuschewski,	  2006).	  The	  sporozoites	  infect	  the	  glands	  via	  attachment	  and	  invasion	  of	  
the	  epithelial	  cells	  using	  surface	  proteins.	  At	  this	  point,	  the	  sporozoites	  are	  ready	  to	  be	  
injected	   along	   with	   the	   saliva	   into	   the	   vertebrate	   host	   when	   taking	   the	   next	   blood	  
meal.	   Once	   in	   the	   vertebrate	   host,	   the	   sporozoites	  move	   into	   the	   blood	   stream	   via	  
which	   they	   reach	   the	   liver.	   Upon	   reaching	   the	   liver	   sinusoids,	   they	   cross	   the	  
endothelial	  layer	  to	  reach	  the	  hepatocytes.	  Surface	  proteins	  are	  again	  essential	  for	  this	  
interaction,	   with	   circumsporozoite	   protein	   and	   thrombospondin-­‐related	   adhesive	  
protein	   providing	   interaction	   with	   glycoproteins	   on	   the	   surface	   of	   hepatocytes.	  
Sporozoites	   will	   migrate	   through	   a	   number	   of	   hepatocytes	   before	   establishing	   an	  
infection	  and	   forming	  a	  parasitophorous	  vacuole,	  starting	  exoerythrocytic	  schizogony	  
(Mota	  et	  al.,	  2001).	  	  
1.1.7	  The	  pellicle	  
The	  pellicle	   is	   a	   trilaminar	   cortical	   structure	   that	   provides	   flexibility	   and	   strength	   for	  
migration	  and	  invading	  the	  host	  cell.	  It	  contains	  three	  major	  components:	  the	  plasma	  
membrane,	  the	   inner	  membrane	  complex	  (IMC),	  and	  the	  subpellicular	  network	  (SPN)	  
consisting	  of	   intermediate	   filaments	   (Fig	  1.3).	  A	   system	  of	   subpellicular	  microtubules	  
run	   perpendicular	   beneath	   this	   subpellicular	   network,	   from	   the	   apical	   polar	   ring	  




membrane	   and	   consists	   of	   a	   system	   of	   flattened	   vacuoles	   derived	   from	   the	  
endoplasmic	   reticulum.	   The	   IMC	   contains	   intramembranous	   particles	   that	   run	  
alongside	   the	   subpellicular	   microtubules,	   suggesting	   that	   they	   could	   link	   these	   two	  
structures.	  Tightly	  connected	  to	  the	  IMC	  on	  the	  cytoplasmic	  side	  is	  the	  SPN.	  The	  SPN	  
was	   first	   characterised	   in	   the	   apicomplexan	   parasite	   Toxoplasma	   gondii	   (Mann	   and	  
Beckers,	  2001).	  The	  presence	  of	  the	  SPN	  was	  confirmed	  from	  detergent	  extraction	  of	  
T.	  gondii	  tachyzoites,	  revealing	  a	  two	  dimensional	  network	  of	  interwoven	  intermediate	  
filaments	  on	  the	  cytoplasmic	  surface	  of	  the	  IMC.	  The	  SPN	  maintains	  the	  shape	  of	  the	  
cell	  and	  is	  resistant	  to	  detergent	  extraction,	  indicating	  that	  it	  is	  a	  membrane	  skeleton	  
of	  the	  parasite,	  providing	  mechanical	  strength	  (Mann	  and	  Beckers,	  2001).	  In	  T.	  gondii,	  
variations	   in	   the	   stability	   of	   the	   subpellicular	   network	  were	   reported	   in	  mother	   and	  
daughter	   cells	   (Harding	   and	   Meissner,	   2014).	   Developing	   parasites	   had	   detergent-­‐
soluble	   SPN,	   whereas	   mature	   parasites	   had	   detergent-­‐resistant	   SPN	   (Mann	   et	   al.,	  
2002).	  Ookinetes	  have	  40-­‐60	  microtubules,	  sporozoites	  18-­‐19,	  and	  merozoites	  as	  few	  
as	  2-­‐3.	  	  
	  
Fig	  1.3	  The	  pellicle	  trilaminar	  complex	  found	  in	  the	  motile	  zoite	  stages	  of	  malaria	  with	  the	  plasma	  membrane,	  inner-­‐




1.1.8	  The	  alveolins	  
Through	   investigating	   the	   SPN	   in	   Toxoplasma	   gondii,	   Mann	   and	   Beckers	   (2001)	  
identified	  the	  protein	  TgIMC1	  as	  a	  major	  constituent.	  This	  led	  to	  the	  identification	  of	  a	  
family	  of	  structurally-­‐related	  proteins	  in	  apicomplexan	  parasites,	  initially	  named	  IMC1	  
proteins	  (Khater	  et	  al.,	  2004).	  This	  protein	  family	  was	  later	  renamed	  ‘alveolins’	  due	  to	  
their	  restricted	  presence	  in	  alveolates	  (Gould	  et	  al.,	  2008).	  Thirteen	  alveolins	  have	  now	  
been	   identified	   in	   Plasmodium	   (Table	   1.1)	   (Al-­‐Khattaf	   et	   al.,	   2015)	   and	   fourteen	   in	  
Toxoplasma	   (Anderson-­‐White	   et	   al.,	   2011).	   The	   structurally	   homologous	   domains	   of	  
the	   alveolins	   are	   characterized	   by	   possessing	   tandem	   repeat	   sequences	   of	   twelve	  
amino	   acids	   that	   are	   thought	   to	   constitute	   the	   filament-­‐forming	   properties	   of	   these	  
proteins	   similar	   to	   the	   coiled-­‐coil	   domains	   of	   other	  metazoan	   intermediate	   filament	  
proteins	   (Al-­‐Khattaf	   et	   al.,	   2015),	   such	   as	   the	   keratins.	   Alveolins	   share	   sequence	  
homology	  with	  articulins	  and	  plateins,	  cytoskeletal	  proteins	  of	  free-­‐living	  protists	  that	  
also	  possess	   12	   amino	   acid	   tandem	   sequences	   (Al-­‐Khattaf	  et	   al.,	   2015).	   The	   average	  
protein	  helix	   is	   12	  amino	  acids	   in	   length	   (Presta	  and	  Rose,	  1988),	   further	   supporting	  
the	  argument	  that	  these	  tandem	  repeats	  may	  form	  an	  α-­‐helical	  coiled-­‐coil	  secondary	  
structure.	   The	   Plasmodium	   alveolins	   are	   differentially	   expressed	   in	   zoite	   stages	  
throughout	  the	  life	  cycle	  (Table	  1.1).	  
The	  alveolins	  have	  been	  characterised	  through	  a	  number	  of	  targeted	  gene	  disruptions	  
in	  P.	  berghei	  (Khater	  et	  al.,	  2004,	  Tremp	  et	  al.,	  2014).	  Khater	  et	  al	  (2004)	  found	  that	  the	  
structural	   orthologue	   to	   TgIMC1,	   PbIMC1a,	   is	   involved	   in	   the	   development	   of	   the	  
sporozoite	  and	  essential	  for	  maintaining	  its	  shape,	  tensile	  strength	  and	  motility.	  When	  
knocked	   out,	   it	  was	   found	   that	   the	  mutant	   sporozoites	   could	   not	   infect	   the	   salivary	  




alveolins	   have	   in	   development,	   motility	   and	   infectivity.	   Similar	   roles	   were	   later	  
identified	   for	   the	   ookinete-­‐expressed	   alveolin	   IMC1b	   (Tremp	   et	   al.,	   2008),	   and	   the	  
ookinete	  and	  sporozoite-­‐expressed	  IMC1h	  (Tremp	  and	  Dessens,	  2011).	  	  
Table	   1.1	   A	   list	   of	   all	   13	   identified	   alveolin	   proteins	   and	   the	   currently	   identified	   zoite	   life	   stages	  where	   they	   are	  
expressed.	  Adapted	  from	  (Al-­‐Khattaf	  et	  al.,	  2015).	  
	   LIFE	  STAGE	  EXPRESSED	  
GENE	   Merozoite	   Ookinete	   Sporozoite	  
pbimc1a	   	   	   x	  
pbimc1b	   	   x	   	  
pbimc1c	   x	   x	   x	  
pbimc1d	   	   x	   	  
pbimc1e	   x	   x	   x	  
pbimc1f	   	   	   	  
pbimc1g	   x	   x	   x	  
pbimc1h	   	   x	   x	  
pbimc1i	   	   	   	  
pbimc1j	   	   	   	  
pbimc1k	   	   	   	  
pbimc1l	   	   	   	  
pbimc1m	   	   	   	  
	  
A	   phylogenetic	   analysis	   of	   the	   alveolins	   detail	   the	   evolutionary	   relationship	   to	   one	  
another.	  Results	  from	  Al-­‐Khattaf	  et	  al	  (2015)	  suggest	  that,	  throughout	  the	  13	  alveolin	  
domains,	   there	   is	   a	   significant	   difference	   in	   the	   sequences	   between	   two	   separate	  
alveolin	  domains,	   termed	  alveolin	  domain	  1	   (red)	  and	  alveolin	  domain	  2	   (green)	   (Fig	  
1.5	   A	   and	   B).	   Both	   domains	   are	   defined	   by	   the	   presence	   of	   a	   tandem	   repeat	  
periodicity,	  however	  there	  are	  primary	  structure	  differences	  that	  split	  them	  in	  to	  two	  
clades.	   Whilst	   the	   presence	   of	   alveolin	   domain	   1	   is	   present	   in	   all	   proteins	   (except	  
IMC1d,	   proven	   to	   be	   functionally	   redundant	   (Al-­‐Khattaf	   et	   al.,	   2015)),	   the	   alveolin	  
domain	  2	   is	  present	   in	  4	  out	  of	   the	  13	  alveolins.	  The	  differential	  expression	  of	   these	  
alveolins,	   as	   detailed	   in	   table	   1.1,	   provide	   an	   interesting	   narrative	   alongside	   the	  




proteins.	   For	   example,	   IMC1a	   is	   a	   sporozoite-­‐specific	   alveolin,	   only	   expressed	  during	  
this	   life	   stage.	   Conversely,	   IMC1b	   is	   an	   ookinete-­‐specific	   alveolin.	   IMC1c,	   IMC1e	   and	  
IMC1g,	  however,	  are	  expressed	  in	  all	  three	  zoite	  stages	  of	  the	  malaria	  lifecycle.	  
	  
Fig	  1.4	  A)	  Phylogenetic	  analysis	  of	  the	  alveolins	  	  PbIMC1a	  –	  h,	  with	  numbers	  corresponding	  to	  amino	  acid	  
coordinates	  of	  the	  conserved	  domains	  within	  the	  protein.	  The	  analysis	  shows	  two	  distinct	  clades	  of	  domains,	  type	  1	  
(red)	  and	  type	  2	  (green).	  B)	  a	  schematic	  diagram	  of	  the	  13	  alveolins	  showing	  the	  relative	  positions	  of	  either/both	  
the	  type	  1	  and	  type	  2	  domains.	  Adapted	  from	  Al-­‐Khattaf	  et	  al,.	  2015.	  
	  
Sequence	   analysis	   of	   the	   13	   alveolins	   has	   shown	   that	   IMC1e	   is	   the	   most	   recent	  
common	  ancestor	  of	  the	  alveolins.	  Using	  a	  similarity	  matrix	  from	  BLAST	  scores,	  IMC1e	  
was	  ranked	  as	  being	  the	  most	  representative	  of	  the	  alveolins	  as	  a	  whole,	  detecting	  the	  
most	   number	   of	   alveolins	   in	   BLAST	   homology	   searches.	   This	   is	   in	   comparison	   with	  
IMC1d,	   the	  most	   divergent	   alveolin,	   only	   detecting	   four	   alveolins	   in	   BLAST	   searches.	  
This	  was	  also	   reflected	   in	  other	  genera	  across	   the	  Apicomplexa	  phylum,	   for	  example	  




proteins	  (Anderson-­‐White	  et	  al,.	  2011),	  whilst	  IMC1d	  detected	  only	  five	  (Al-­‐Khattaf	  et	  
al.,	  2015).	  	  
The	  phylogenetic	  clade	  split	  between	  the	  alveolin	  domain	  1	  and	  alveolin	  domain	  2	   is	  
further	   highlighted	   through	   a	   primary	   sequence	   analysis	   of	   the	   domains	   in	   IMC1b	  
showing	  periodicity	  within	  the	  primary	  sequence	  (Fig	  1.5).	  	  
Fig	  	  1.5	  The	  primary	  sequence	  of	  IMC1b	  showing	  the	  12	  amino	  acid	  tandem	  repeat	  periodicity	  identification	  present	  
in	   alveolins	   by	   the	   programme	  HHrepID.	  Alveolin	   domain	   1	   is	   in	   red,	   alveolin	   domain	   2	   is	   in	   green.	   The	   red	   and	  
green	  sections	  coincide	  with	  the	  highly	  conserved	  domains	  that	  define	  an	  alveolin	  domain.	  Similar	  results	  are	  also	  
seen	  in	  closely	  related	  articulins	  and	  plateins.	  Adapted	  from	  (Al-­‐Khattaf	  et	  al,.	  2015).	  	  
	  
The	  areas	  shown	  with	  red	  (domain	  1)	  and	  green	  (domain	  2)	  highlight	  the	  12	  amino	  acid	  
periodicity,	   where	   there	   is	   a	   repetition	   of	   primary	   sequence	   pattern	   across	   both	  
domains.	   This	   further	   adds	   to	   the	   argument	   that	   the	   secondary	   structure	   of	   these	  
proteins	   allow	   for	   intramolecular	   interactions	   between	   alveolins,	   as	   is	   seen	   with	  
intermediate	  filaments.	  	  
The	   alveolin	   domains	   are	   highly	   conserved	   throughout	   Plasmodium	   species,	   with	  
defined	   borders	   surrounding	   the	   areas	   that	   are	   shown	   to	   have	   tandem	   repeat	  









Pb.ANKA        MKIDKNKSASISNHDNEMPNMEKLYDQLSFQKFENESNSSLKYSE--IDKI--SSLNKST 
Pchas          MKTDKNKSTNISKYDNEMPNMEKLYDQLSFQKFENESSSSLKYSD--IEKM--SGLNKSI 
Pyoelii        MKIDKNKSASISNHDNEMPNMEKLYDQLSFPKFEDESNSSLKYSE--IDKI--SSLNKTI 
Pkn.H          MQTTKSKSISALSSESGTTNFSK--------HREMERPSAAKNGA--DEEQFALSLKRSI 
Pviv           MDTTKSKSSSALSSESGTANLPK--------HREMERTAATKNGA--DGEQSALSLNRSI 
Preic.CDC      ----------MSHYNPEQINFVN------------NHRNNVKEGYFYKNNLLKEHINKM- 
Pf.3D7         ----------MSHYNPEQLNFVN------------NHRNNVKEGYFYKNNLLKENNNKM- 
Povale         MEATKSKCTFISNNKEENAKFRKNYEKLIFQQLETETNTPISYSN--HGERLPASFTKSV 
Pmalariae      ---------------------------MKFQNFNIEPRTPLKYGG--KEGRSLSSLRGSI 
                                                  :     . .                 
 
Pb.ANKA        QSFVYSNNTNNSYANTSKSGTRIMNKPNVHIVEKIKEVPTYIVKNQTRIIDVPELRFVNK 
Pchas          QSSIYSNNTSNSYANTPKSGTRIMNKSNVQIVEKIKEVPTYIVKNQTRIINVPEVRFVNK 
Pyoelii        QSSIYSNNTNNSYANTPKSGTRIMNKPNVHIVEKIKEVPTYIVKNQTRIIDVPEVRFVNK 
Pkn.H          SPFTTD----RSYANGQTKDTKLIDSANFDFAGKAVDTKTYITQNKTKVIEVPELRFIDK 
Pviv           PPFSRD----RTYANGQTKETKLIDSANHDFAGKAIDTQTYIPHNKTKVIEVPELRFIDK 
Preic.CDC      --ESSKNCIMVPLINKPSHSENNFSKNNID-ENINEEKSKYQFEYQNKIIQVPELKYVDK 
Pf.3D7         --ESSKNCIMVPLINNPSHSENNFSKNNRD-ENINEEKSKYQFEYQNKIIQVPELKYVDK 
Povale         PPP---SCHSS-IVYTSIKETQIRNKPNIEFVEKIKEVPSYVYQSKNRVIEIPEVTFVDK 
Pmalariae      PISTSSSCSSTCAPNTKEKETKIIQKQNAELVEKIREVPNYIFHNKTKVIEVPELRFIDK 
                                    .  .. * .      :  .*  . :.::*::**: :::* 
 
Pb.ANKA        IEHDTTHVIEKLKYVPKDVTKYNIIKKPVIKNIVKEKKMDVLHVQEKISFRDQEVIEEVY 
Pchas          VEHDTVEVIEKLKYVPKEVTKYNIIKKPVIKNIVKEKKMDVLHVQEKISFRDQEVVEEVY 
Pyoelii        IEHDTVNVIEKLKYVPKDVTKYNIIKKPVIKNIVKEKKMDVLHIQEKISFRDQEVVEEVY 
Pkn.H          IEYDP-FVIEKLRYVPKQVTKYNIIEKPVIKNIVSEKKVDVLYVQEKISFKDQEIVEEVY 
Pviv           IEYDP-FVIEKLRYVPKQVTKYNIIEKPIIKNIVTDRKVDVLYVQEKISFKDQEIVEEVY ALV1 
Preic.CDC      IVYDP-VIIEKVKYVPKDVIKYNIIKKPVIKNIITEKKVDILQVKEKISFKEEEIVEDVY 
Pf.3D7         MVYDP-VIIEKVKYVPKEVIKYNIIKKPVIKNIITEKKVDVLQVKEKISFKEEEIVEDVY 
Povale         IQYDP-VVVEKLKYVPKEVTKYNIIEKPVIKNIVTEKKVDVLHVQEKISFKDQEIVEEVY 
Pmalariae      IEYDP-QVIEKIKYVPKEVTKYNIIEKKVINNIVTEKKVDVLQVQEKIRFKDQEIVEEVY 
               : :*   ::**::****:* *****:* :*:**:.::*:*:* ::*** *:::*::*:** 
 
Pb.ANKA        NYVDKDGNKIKDHNDIMTMDYNLSNENESNRK-IDYPVYPSLNC---------------- 
Pchas          NYVDEDGNQIKDSQDIMTMDYILSNENESNKK-RECPVYPSLNC---------------- 
Pyoelii        NYVDKDGNQIKDHNDIMTMDYIQSNENESNRK-TDCPVYSSLNC---------------- 
Pkn.H          NYVDKDNNRILADQGSPSLDRSALPITEMTQGEWDSSALSPHVNSDIR--------RNSI 
Pviv           NYVDKDNQRILADQGGPSPSRAVLPLGGTTRGECDSSASCPYINGDII--------RNSM 
Preic.CDC      NYVDKDLNTKWNESQYDNEMYKDLTKKKNYIG-----------QNHLL----P------- 
Pf.3D7         NYVDKDLNTKWNESQYDNEMYKDLTKKKNYIG-----------QNHLL----P------- 
Povale         HYVDKDNNTYVKDHGSSTKIKRSLVEGDMHRK-FDYPAYQPARSSNTNGANVPNVGNYGS 
Pmalariae      HYVDKDNNRFINKQGISTENYTSSKDKGVNEK-FDQLTYQYINN---------------- 
               :***:* :         .                                           
 
Pb.ANKA        --CNNT--SAYIENSNNICSMLCDNKDENTNIIEKSK---------RENLPYDVNINMLP 
Pchas          --CNNT--SAYVENSNNICSMAYNNKIDNSNIIGISK---------GETLPYDVDLNVLP 
Pyoelii        --CNNT--SAYIENSNNICSMVCNNKDENTNIIEKSK---------RENLPYDVDLNMLP 
Pkn.H          HNSNNHN--------------------------------------DNRNSMGGASDGVLP 
Pviv           HHCNNHN--------------------------------------DSRSSMGGAPDGVLP 
Preic.CDC      ---------------NNINKMG-----------------------HINDCTYKHINNNIT 
Pf.3D7         ---------------NNINKMG-----------------------HINDRTYKHINNNIT 
Povale         NICNNHDNAMYEMHANDVCEMHDSDVYDMQDNAVYDRHDNAVYNMYDNDVFDNQCSRALP 
Pmalariae      -----------------------------------------NINTSNDIDYTKSCGSQLP 
                                                                         :  
 
 
Pb.ANKA        PLLEPFGPQIKTEDNKIFENVFVPKVEKIVEVQKKIDIPINLPVPYIVPKPKIIDVDIPV 
Pchas          PLLEPFGPQIKTEDNKIFENVFVPKVEKVVEVQKKIDIPINLPVPYIVPKPKIIDVDIPV 
Pyoelii        PLLEPFGPQIKTEENKIFENVFVPKVEKVVEVQKKIDIPINLPVPYIVPKPKIIDVDIPV 
Pkn.H          SLLEPFGPQVNITENKIFENVFIPKVEKVVEVKNKIDIPINLPVPYIVPKPKIVDVDIPV 
Pviv           PLLEPFGPQVNVTENKIFENVFVPKVEKVVEVKKKIDIPINLPIPYIVPKPKIVDVDIPV 
Preic.CDC      NLLEPFGPQIDVEENKIIENVFVPNVEKVIEVNKKIDIPINLPVPYIVPKPKIIDVDVPV 
Pf.3D7         NLLEPFGPQIDVEENKIIENVFVPNVEKVIEVNKKIDIPINLPVPYIVPKPKIIDVDVPV 
Povale         PLLEPFGPQVNVEDNKTFENVFVPKVEKVVEVKKKIDIPINLPVPYIVPKPKIIDVDVPV 
Pmalariae      PLMEPFGPQVYLGENKTFENIFIPKVEKVVEVKKKIDIPINLPIPYIVPKPKVIDVDVPV 






Fig	  1.6	  A	  Clustal	  Omega	  alignment	  of	  various	  Plasmodium	  species	  IMC1b	  primary	  sequences,	  and	  the	  regions	  of	  high	  
conservation	  between	  the	  alveolin	  domains,	  denoted	  with	  ALV	  1,	  for	  domain	  type	  1,	  ALV	  2	  for	  domain	  type	  2,	  and	  
ALV	  3	  for	  a	  third	  conserved	  domain.	  Produced	  using	  software	  from	  (Madeira	  et	  al.,	  2019)	  
	  
A	   Clustal	   Omega	   (Madeira	   et	   al.,	   2019)	   multiple	   amino	   acid	   alignment	   further	  
highlights	  the	  structural	  similarities	  between	  the	  alveolins	  across	  Plasmodium	  species.	  
The	  presence	  of	  a	  third	  highly	  conserved	  domain,	  domain	  3,	  shows	  no	  tandem	  repeat	  
periodicity	  as	  seen	  in	  domain	  types	  1	  and	  2,	  and	  is	  therefore	  not	  a	  true	  alveolin.	  This	  
third	  domain	  is	  found	  in	  both	  IMC1b	  and	  IMC1h.	  Its	  contribution	  to	  the	  function	  of	  the	  
protein	  is	  not	  known.	  	  
	  
Pb.ANKA        FKFNDKYVPVPVRQKIIPKVTWSDKVYKIDCIIEKPYLVYHDIIKFVPTDTKINIREYPK 
Pchas          FKFNDKYVPVPVRQKIIPKITWSDKVYKVDCVIEKPYLVYHDIIKFVPTDTKISVREYPK 
Pyoelii        FKFNDKYVPVPVRQKIIPKVTWSDKVYKVDCIIEKPYLVYHDIIKFVPTDTKINVREYPK 
Pkn.H          FKFNDKYVPVPIRQRIIPKVTWTDKVYKVDCVVEKPYLVYHDIVKIVPTDTKISVREYPK 
Pviv           FKFNDKYVPVPVRQRIIPKVTWTDRVYKVDCVVEKPYLVYHDIVKIVPTDTQISVREYPK ALV2 
Preic.CDC      FKFNDKYVPVPVSKKIIPKITWTDKIYQVDCLIEKPYLVYHNIIKMVPTDSKITVREYPK 
Pf.3D7         FKFNDKYVPVPVSKKIIPKITWTDKIYQVDCLIEKPYLVYHNIIKMVPTDSKITVREYPK 
Povale         FKFNDKYIPVPVRQKIIPKVTWSDKVYQVDCVIEKPYLVYHDIIKFVPCDSKIMVREYPR 
Pmalariae      FKFNDTYVPVPVRQRIIPKVTWSDKVYKVDCLVEKPYLVYHNIIKVVPTDSKITIREYPK 
               *****.*:***: ::****:**:*::*::**::********:*:*.** *::* :****: 
 
Pb.ANKA        GINKINPEELYEADNLALWMRVNADLKEEKDKLKKNT---------------QSDSMLDH 
Pchas          GINKINPEELYEADNLALWMRVNADLKEEKDNLKKNT---------------QTESTIDH 
Pyoelii        GINKINPEELYEADNLALWMRVNADLKEEKDNLKKSA---------------QPDIILDH 
Pkn.H          GITKINPEELYEVDNLALWMRVNADLKEEKDALKKTQ-----------------DNFSDH 
Pviv           GITKINPEELYEVDNLALWMRVNADLKEEKDALKKTQ-----------------DNCSDR 
Preic.CDC      GIKKINPEELYEVDNLALWMRVNADLKQEHDQMKNEKYETNKKKGKGETEELDDNILSDH 
Pf.3D7         GIKKINPEELYEVDNLALWMRVNADLKQEHDQMKNEKYETNKKKGKGETEQLDDNISSDH 
Povale         GITKINQDELYEVDNLALWMRVNADLKEEKDKL----------------------NLSDH 
Pmalariae      GINKINTEELYEADNLALWMRVNADLKHEKDKLKKTQ-----------------DSLSDH 
               **.*** :****.**************.*:* :                         *: 
 
Pb.ANKA        ICECSDCE-TCEHISN-SELNISHD-LSNIKYSPNNFYDTIPLHQDHPLEMVHLQNKWMK 
Pchas          ICECSDCE-TCEHISN-SELNISHD-LFNTKSSPNNFSDTIPLHQDHPLEMVHLQNKWMK 
Pyoelii        ICECSDCE-TCEHISN-SELNISHD-LSNIKSSPNNFSDTIPLHQDHPLEMVHLQNKWMK 
Pkn.H          TCECSNSD-SFEECSSTTELNSYQDGATTIKSSNENVLDTLPIHPGHPLEIVHLQNKWIK 
Pviv           TCECSIAD-SFEECSSTSELNSSQDGATTIKSSNENVLDTLPIHPGHPLEMVHLQNKWMQ ALV3 
Preic.CDC      TCECSESYETYGKLSN-GEFNSSNE-ETTIKSSNENILDTLPLHPGHPLEFIHLQNKWIS 
Pf.3D7         TCECSESYETYEKLSN-EEFNSSNE-ETTIKSSNENILDTLPLHPGHPLEFIHLQNKWIN 
Povale         TCECSDCD-SYEEVSN-TELNSSQD-VSTIKSSNENLSNTMPIHPGHPLEIIHLQNKWIK 
Pmalariae      TCECSDCD-TYEQNSN-SELNSSQD-ATTIKSSNENLLSTLPLHPGHPLEITHLQNKWIK 
                **** .  :  . *.  *:*  ::   . * * :*. .*:*:* .****: ******:. 
 
Pb.ANKA        KDTTKIPELYNEQFMNAHRNAFFNLTSKIPREAKVEMKTISQLKTNT------------- 
Pchas          QDATKIPELYNEQFMNAHRNAFFNLTSKIPREAKVEMKTIAQLKTNT------------- 
Pyoelii        QDTTKMPELYNEQFMNAHRNAFFNLTSKIPREAKVEMKTISQLKTNT------------- 
Pkn.H          QDTTRMQELYQDGFFDAHRNAMFNLGTRIPREAEIEVRQIAQLQRFGEKREYDN------ 
Pviv           QDTTRMMELYQDGFFDAHRNAVFNLATRIPREAEIEVRQISQLQRRMEKRECGTD----- 
Preic.CDC      QDTTNIPDMYDQKYLDAHRNAVFNLTTQMPREAEVEAKQLLYIQKKLQQEETL------- 
Pf.3D7         QDTTNIPDMYDQKYLDAHRNAVFNLTTQMPREAEVEAKQLLYIQKKLQQEETL------- 
Povale         QDTTKTSELYSEQFLEAHKNAIFNLSTRLPREAEIDIKQIFAKPKEDR------------ 
Pmalariae      QETTRIPELYEEKFLDANRNAVFNLSTQIPREAEIEAKQMFQMQKQMDKRELNTISGKLF 




1.1.9	  Plasmodium	  motility	  
Plasmodium	  utilise	  gliding	  motility	  to	  migrate	  and	  egress	  through	  various	  tissues	  in	  the	  
zoite	  stages	  of	  its	  life	  cycle,	  in	  both	  invertebrate	  and	  vertebrate	  hosts.	  It	  is	  a	  substrate	  
dependent	  form	  of	  locomotion,	  requiring	  a	  substrate	  from	  which	  the	  parasite	  is	  able	  to	  
inversely	  propel	   itself	  against	   the	  direction	  of	   force	   (Heintzelman,	  2006,	  Baum	  et	  al.,	  
2008).	   Throughout	   these	  motile	   life	   stages,	   the	   glideosome	   proteins	   are	   conserved,	  
highlighting	  the	  importance	  of	  these	  structures	  for	  the	  motility	  of	  the	  parasite.	  These	  
include	  proteins	  such	  as	  the	  myosin	  motor,	  myosin	  light	  chains,	  glideosome	  associated	  
proteins	   (GAP40,	   GAP45,	   GAP50,	   GAPM)	   and	   parasite	   adhesins	   (for	   example	   TRAP,	  
thrombospondin-­‐related	  anonymous	  protein	  in	  sporozoites)	  (Fig	  1.7).	  The	  fluid-­‐mosaic	  
model	  of	  lipid	  bilayers	  allows	  for	  explanation	  of	  movement	  of	  the	  parasite.	  This	  allows	  
for	   the	   physical	   interaction	   of	   the	   parasite	   adhesin	   and	   the	   host	   substrate	   to	   be	  
maintained	  whilst	  the	  parasite	  glides.	  Due	  to	  the	  amount	  of	  force	  required	  to	  move	  the	  
parasite,	   it	   has	   been	   suggested	   that	   the	   alveolins,	   through	   the	   SPN,	   provide	   a	   solid	  
structure	   for	   the	   complex	   to	   allow	  movement,	   much	   like	   the	   pivot	   point	   of	   an	   oar	  
whilst	  rowing	  (Baum	  et	  al.,	  2008).	  This	  hypothesis	  is	  consistent	  with	  the	  demonstrated	  
reduction	  in	  zoite	  motility	  of	  alveolin	  knockout	  parasites	  (Khater	  et	  al.,	  2004,	  Tremp	  et	  






Fig.	  1.7	  The	  substrate	  dependent	  gliding	  motility	  model	  for	  Apicomplexan	  parasite	  movement.	  The	  parasite	  adhesin	  
is	  a	  transmembrane	  protein	  that	  interacts	  with	  host	  substrate,	  attached	  through	  its	  C-­‐terminal	  domain	  to	  the	  
actomyosin	  motor	  domain.	  The	  myosin	  motor	  domain	  (MyoA),	  essential	  light	  chain	  (ELC1)	  and	  myosin	  light	  chain	  
(MLC)	  are	  stabilised	  by	  the	  presence	  of	  GAP45,	  and	  anchored	  in	  place	  by	  GAP40	  and	  GAP40.	  The	  complex	  interacts	  
with	  the	  rigid	  alveolin-­‐rich	  subpellicular	  network	  through	  the	  GAPM	  protein.	  The	  MyoA	  protein	  is	  secured	  with	  ELC1	  
and	  MLC1	  in	  the	  lever-­‐arm	  domain.	  MyoA	  drives	  ATP-­‐dependent,	  barbed	  end	  directed	  force,	  which,	  through	  F-­‐actin,	  
propels	  the	  secreted	  parasite	  adhesin	  inversely	  to	  the	  direction	  of	  movement	  through	  the	  fluidity	  of	  the	  outer	  
plasma	  membrane.	  Adapted	  from	  (Williams	  et	  al.,	  2015,	  Baum	  et	  al.,	  2006).	  	  
	  
1.1.10	  Intermediate	  filaments	  
Intermediate	   filaments	   are	   proteins	   that	   provide	   a	   structural	   role	   in	   the	   cell,	   largely	  
giving	  mechanical	   strength	  to	  cells	  and	  tissues.	   Intermediate	   filaments	  are	  classed	  as	  
such	  as	   they	   tend	   to	  have	  a	  diameter	  of	  ~10nm,	  which	   is	   intermediate	  between	   the	  
diameters	  of	  the	  two	  other	  main	  components	  of	  the	  cytoskeleton,	  actin	  (around	  7nm)	  
and	   microtubules	   (around	   25nm)	   (Herrmann	   et	   al.,	   2009).	   Another	   feature	   of	  
intermediate	   filaments	   is	   that	   they	   are	   amorphous,	   with	   no	   polarity.	   Intermediate	  




of	  intermediate	  filaments	  currently	  classified	  in	  eukaryotes.	  Type	  I	  and	  II	  are	  keratins,	  
type	   III	   include	  vimentin	  and	  desmin.	  Type	   IV	   include	  neurofilament	  proteins,	   type	  V	  
include	  nuclear	  lamins,	  and	  type	  VI	  includes	  nestin	  (Hyder	  et	  al.,	  2011,	  Herrmann	  et	  al.,	  
2009).	  	  
Despite	   there	   being	   little	   homology	   regarding	   size	   and	   amino	   acid	   sequence,	   both	  
between	  and	  across	  these	  groups	  of	  intermediate	  filaments,	  they	  all	  share	  a	  common	  
secondary	  structure	  organisation,	  most	  notably	  a	  central	  helical	   rod	  domain	  that	  can	  
form	   coiled-­‐coils.	   Archetypal	   coiled-­‐coil	   domains	   are	   made	   up	   of	   a	   heptad-­‐repeat	  
structure	  that	  contain	  an	  a-­‐b-­‐c-­‐d-­‐e-­‐f-­‐g	  conformation	  (Fig	  1.8).	  Residues	  at	  positions	  a	  
and	  d	  that	  are	  sequentially	  hydrophobic,	  allowing	  for	  the	  orientation	  of	  the	  residues	  to	  
be	  buried	  within	  the	  structure.	  Residues	  at	  positions	  g	  and	  e	  are	  charged	  positively	  and	  
negatively	   respectively,	   interacting	  with	   each	  other	   and	   forming	  non-­‐covalent	   bonds	  
(Hicks	   et	   al.,	   1997).	   The	   coiled-­‐coil	   domains	   are	   thought	   to	   be	   important	   for	   the	  
filament-­‐forming	   properties	   of	   the	   intermediate	   filaments.	   This	   offers	   an	   interesting	  
parallel	  with	   the	   alveolins,	  which	   also	   possess	   tandem	   repeat	   structures,	   albeit	   of	   a	  
different	  periodicity.	  
	  
Fig	  1.8	  The	  heptad	  repeat	  structure.	  Residues	  a	  –	  g	  are	  indicated	  with	  arrows	  indicating	  the	  primary	  sequence,	  
forming	  a	  coiled-­‐coil	  with	  two	  parallel	  helices.	  Residue	  g	  is	  positively	  charged,	  whereas	  residue	  e	  is	  negatively	  





Filament	   forming	  β-­‐sheets	  are	   seen	  within	  β-­‐keratins	  of	  avian	   feathers,	  however	   the	  
structure	   and	   sequence	   of	   these	   filaments	   do	   not	   correspond	  with	   alveolin	   primary	  
sequences	   or	   the	   12	   amino	   acid	   tandem	   periodicity	   (Fraser	   and	   Parry,	   2008),	   with	  
further	   evidence	   suggesting	   periodicity	   between	   two	   types	   of	   keratin,	   scale	   and	  
feather	   keratins,	   have	   structural	   similarity	   (Gregg	   et	   al.,	   1984).	   	   With	   the	   filaments	  
readily	  produced	  from	  natural	  feather	  growth,	  X-­‐ray	  diffraction	  patterns	  were	  readily	  
produced	   directly	   from	   the	   feather	   rachis	   (Fraser	   et	   al.,	   1971),	   limiting	   the	  
methodological	   approach	   for	   characterising	   these	   proteins	   in	   vivo.	   However,	  
intermediate	   filaments	   ability	   to	   form	   simultaneously	   rigid	   and	   flexible	   filaments	  
remains	   remarkable.	   Their	   ability	   to	   form	   dimers	   by	   associating	   laterally	   and	   in	   an	  
antiparallel	  fashion	  allow	  them	  to	  form	  these	  stable	  structures	  (Robert	  et	  al.,	  2016).	  	  
Insoluble	  by	  their	  filament-­‐forming	  nature,	  expression	  and	  purification	  of	  intermediate	  
filament	   proteins	   provide	   a	   set	   of	   challenges	   that	   differ	   to	   soluble	   proteins.	   These	  
insoluble	  proteins	  have	  had	  their	  atomic	  structures	  resolved	  through	  harsh	  denaturing	  
conditions.	  They	  are	  able	  to	  be	  solubilised	  by	  cells	  through	  various	  kinases	  that	  reduce	  
them	  down	   to	   their	   characteristic	   coiled-­‐coil	   complexes	   (Herrmann	   and	  Aebi,	   2016).	  
Vimentin	   has	   been	   characterised	   through	   extensive	   efforts	   over	   a	   number	   of	   years	  
(Nicolet	  et	  al.,	  2010).	  Though	  challenging,	  results	  were	  obtained	  through	  using	  multiple	  
fragments	   of	   vimentin,	   between	   60-­‐100	   residues	   each,	   and	   were	   expressed	   in	  
Esherichia	  coli	  using	  an	  N-­‐terminal	  6×His	  tag	  and	  a	  TEV	  protease	  cleavage	  site	  (Nicolet	  
et	   al.,	   2010).	   Proteins	   were	   expressed	   and	   induced	   using	   common	   techniques	   and	  
purified	   using	   ion-­‐exchange	   chromatography	   and	   size	   exclusion	   chromatography	   in	  
highly	   denaturing	   buffers	   (Nicolet	   et	   al.,	   2010).	   These	   methods	   provide	   a	   basis	   for	  




1.1.11	  Recombinant	  protein	  expression	  systems	  
Structural	   biology	   has	   provided	   a	   significant	   advancement	   in	   understanding	   the	  
biomolecular	   structure	   of	   various	   proteins	   essential	   for	   cellular	   processes.	   This	  
discipline	  of	  biology	  involves	  studying	  anything	  from	  the	  structure	  and	  function	  of	  the	  
protein,	   to	   its	   localisation	   or	   protein	   interactions.	   Using	   cellular	   protein	   expression	  
systems,	   large	   amounts	   of	   a	   protein	   of	   interest	   can	   potentially	   be	   obtained.	   Both	  
eukaryotic	   and	   prokaryotic	   protein	   expression	   systems	   are	   widely	   used	   in	   research	  
today,	   with	   each	   system	   having	   various	   strengths	   and	  weaknesses.	   The	   selection	   of	  
each	   system	  depends	   on	   the	   type	   of	   protein,	   the	   requirements	   of	   post-­‐translational	  
modifications	   and	   other	   modifications	   for	   functional	   activity,	   and	   the	   desired	   yield.	  
Bacterial	   expression	   systems	   (E.	   coli)	   are	   relatively	   reliable	   in	   producing	   proteins	   for	  
structural	  analysis,	  and	  are	  scalable	  for	  producing	  large	  yields	  quickly.	  It	  has	  a	  low	  cost	  
and	  simple	  culture	  conditions,	  allowing	   for	  optimal	  expression.	  Disadvantages	  of	   this	  
system	  include	  a	  lack	  of	  post-­‐translational	  modifications	  of	  the	  protein	  that	  would	  be	  
seen	  in	  eukaryotic	  systems,	  and	  there	  may	  be	  a	  need	  for	  protein-­‐specific	  optimisation	  
steps.	  There	  are	  a	  number	  of	  hurdles	  to	  tackle	  when	  using	  bacteria	   to	  overexpress	  a	  
desired	   protein.	   As	   energy	   and	   cellular	   resources	   are	   being	   spent	   to	   overexpress	   a	  
protein	  the	  bacteria	  may	  not	  deem	  beneficial,	  a	  number	  of	  proteases	  may	  be	  deployed	  
to	  recycle	  spent	  protein	  resources	  (Paraskevopoulou	  and	  Falcone,	  2018).	  The	  addition	  
of	   protein	   tags	   such	   as	   glutathione-­‐S-­‐transferase	   (GST)	   partly	   protect	   against	   such	  
proteolytic	   degradation.	   Limiting	   the	   amount	   of	   proteases	   innately	   expressed	   in	  
bacteria	  can	  counteract	  this.	  Overexpression	  can	  also	  lead	  to	  high	  protein	  insolubility,	  
with	  aggregated	  protein	  being	  produced	  which	  is	  useless	  for	  structural	  studies.	  The	  N-­‐
utilisation	  substance	  protein	  A	   (NusA)	   tag	  confers	   stability	  and	   increases	  solubility	  of	  




Furthermore,	   protein	   tags	   can	   be	   used	   for	   the	   purpose	   of	   affinity-­‐based	   protein	  
purification,	  the	  best	  example	  perhaps	  being	  the	  polyhistidine	  (His)	  tag,	  which	  is	  small	  
and	   unlikely	   to	   affect	   protein	   folding,	   and	   can	   be	   used	   for	   ion-­‐exchange	  
chromatography	  on	  Nickel	  or	  Cobalt	  cation	  columns.	  Larger	  tags	  such	  as	  GST	  or	  NusA	  
have	  to	  be	  cleaved	  off	  the	  fusion	  protein	  before	  embarking	  on	  structural	  analysis.	  For	  
this	   purpose,	   specific	   protease	   cleavage	   sites	   are	   introduced	   at	   the	   protein-­‐tag	  
junction.	  The	  tobacco	  etch	  virus	  (TEV)	  protease	  cleavage	  site	  (ENLYFQS)	  is	  commonly	  
used,	   as	   it	   is	   small	   and	   can	   be	   efficiently	   cleaved	   by	   TEV	   protease	   in	   vitro	   (cleaving	  
between	  the	  glutamine	  and	  serine	  residues).	  	  	  
1.1.12	  Plasmodium	  berghei	  as	  a	  research	  model	  
The	  ethics	   and	   feasibility	   of	   investigating	   the	  whole	   life	   cycle	   of	   human	  Plasmodium	  
species	  makes	  it	  difficult	  to	  study	  life	  stages	  that	  cannot	  be	  cultured	  in	  the	  laboratory.	  
P.	   berghei	   is	   a	   closely	   related	   species	   that	   infects	   rodents,	   and	   has	   been	   widely	  
validated	  as	  a	  model	  for	  human	  malaria,	  allowing	  for	  investigation	  in	  to	  all	  aspects	  of	  
the	  life	  cycle.	  As	  they	  are	  the	  same	  genus,	  they	  share	  many	  of	  the	  same	  structures	  and	  
cellular	  biology.	  Further	  similarities	  between	  P.	  berghei	  and	  P.	  falciparum	  include	  their	  
genome	   organisation,	   size	   and	   synteny.	   	   The	   P.	   berghei	   genome	   size	   18.5Mb	   as	  
opposed	   to	   P.	   falciparum’s	   23.3Mb,	   and	   both	   have	   14	   chromosomes	   (Otto	   et	   al.,	  
2014).	  	  
It	  is	  possible	  to	  safely,	  simply	  and	  efficiently	  manipulate	  the	  entire	  P.	  berghei	  life	  cycle	  
with	  both	  definitive	  and	   intermediate	  hosts.	   It	   is	   also	  possible	   to	   scale	  up	  and	   study	  
specific	  life	  cycle	  stages	  due	  to	  reliable	  in	  vitro	  protocols,	  particularly	  for	  the	  ookinete.	  
Indeed,	  P.	  berghei	  has	  been	  widely	  used	  as	  a	  model	   for	  malaria	  due	  to	   the	  ability	   to	  




detailed	   studies	   on	   gametogenesis,	   fertilisation	   and	   zygote	   development	   (Rosales-­‐
Ronquillo	  and	  Silverman,	  1974,	  Weiss	  and	  Vanderberg,	  1977).	  As	  a	  high	  number	  of	  the	  
Plasmodium	  alveolin	   repertoire	  are	  expressed	   in	   the	  ookinete,	   this	   is	  a	  key	   life	  stage	  
for	  many	  investigations	  throughout	  this	  thesis,	  highlighting	  the	  suitability	  of	  P.	  berghei	  
as	   the	  chosen	  malaria	  model.	  P.	  berghei	   is	  easily	  maintained	  with	  one	  of	   the	  human	  
malaria	  vectors	  Anopheles	  stephensi,	  and	  allows	  for	  efficient	  and	  stable	  gene	  targeting	  
techniques	  using	   selectable	  markers.	  The	  easily	  manipulated	  genetics	  of	   the	  parasite	  
make	   it	   an	   attractive	   experimental	   organism.	   The	   ability	   to	   transfect	   P.	   berghei	  
merozoites	   is	   advantageous,	   as	   transfecting	   life	   cycle	   stages	   that	   are	   still	  within	   red	  
blood	  cells	  decreases	  the	  efficiency	  of	  transfecting	  DNA	  across	  multiple	  membranes	  to	  
reach	  the	  parasite	  nucleus.	  
Whilst	   reminiscent	   of	   human	   malarial	   infection,	   it	   is	   worth	   considering	   that	   the	  
complexity	   and	   spectrum	   of	   disease	   seen	   in	   humans	   is	   not	   replicated	  within	  mouse	  
models	   of	   malaria,	   due	   to	   the	   number	   of	   strategies	   the	   parasite	   has	   developed	   to	  




1.2	  Aims	  and	  objectives	  
This	   project	   aims	   to	   determine	   the	   core	   architecture	   and	   atomic	   structure	   of	   the	  
alveolins,	   as	   well	   as	   the	   underlying	  mechanisms	   for	   their	   assembly	   into	   the	   cortical	  
cytoskeleton	   of	   malaria	   parasites.	   The	   essential	   nature	   of	   the	   alveolins	   in	   malaria	  
parasite	  development,	  their	  expression	  throughout	  the	  life	  cycle,	  and	  their	  absence	  in	  
vertebrates	   makes	   them	   potentially	   attractive	   drug	   targets	   for	   malaria	   treatment,	  
prophylaxis	   and	   transmission	   control,	   for	   example	   by	   inhibiting	   filament	   formation.	  
Moreover,	   such	   drugs	   may	   be	   active	   against	   a	   broad	   range	   of	   other	   apicomplexan	  
parasites,	   as	   well	   as	   against	   related	   pathogenic	   alveolates.	   In	   this	   context,	   a	   better	  
understanding	   of	   the	   core	   architecture	   of	   the	   alveolins,	   their	   assembly	  mechanisms,	  
and	   domain-­‐specific	   contributions	   to	   alveolin	   function	   is	   vital.	   The	   following	  
hypothesis-­‐driven	  questions	  will	  be	  addressed:	  	  
	  
1:	   Do	   the	   conserved	   alveolin	   domains	   have	   a	   crucial	   role	  within	   the	   proteins	   innate	  
functions	   in	   motility,	   tensile	   strength,	   and	   recruitment	   to	   the	   SPN?	   This	   will	   be	  
addressed	  through	  structure-­‐function	  studies	  using	  transgenic	  parasite	  lines	  expressing	  
modified	  forms	  of	  the	  alveolins	  IMC1b	  and	  IMC1h.	  	  
2:	  Do	  alveolins	   form	  α-­‐helical	   coiled-­‐coil	  domains	  similar	   to	   the	  coiled-­‐coil	   regions	  of	  
metazoan	  intermediate	  filament	  proteins	  that	  are	  required	  for	  IF	  formation?	  This	  will	  
be	   addressed	   using	   recombinant	   expression	   in	   E.	   coli,	   followed	   by	   purification	   and	  
downstream	  structural	  analyses,	  of	  conserved	  domains	  from	  IMC1e,	  IMC1g	  and	  IMC1c.	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This	   chapter	  describes	   the	   general	  methods	  used	   throughout	   these	   results	   chapters.	  
Specific	  protocols	  related	  to	  particular	  chapters	  are	  described	  in	  each	  one	  separately.	  
Chemicals	  used	  were	  purchased	  from	  Sigma	  Aldrich	  unless	  otherwise	  specified.	  
	  
2.1.	  In-­‐Fusion	  cloning	  	  	  
Rather	   than	   using	   traditional	   restriction	   enzyme	   digestion	   combined	   with	   T4	   DNA	  
ligase	  to	  introduce	  PCR	  fragments	  into	  plasmids,	  In-­‐Fusion	  cloning	  was	  used	  (In-­‐Fusion	  
Kit,	  Clontech/Takara	  Bio).	  To	  achieve	  In-­‐Fusion,	  forward	  and	  reverse	  PCR	  primers	  were	  
designed	   to	   contain	   at	   least	   15	   bases	   of	   homology	  with	   the	   sequences	   flanking	   the	  
targeted	  insertion	  site	  in	  the	  cloning	  plasmid.	  Using	  these	  primers,	  amplification	  of	  the	  
DNA	  was	  performed,	  and	  purified	  PCR	  product	  was	  introduced	  into	  a	  linearized	  cloning	  
vector	   in	   the	   In-­‐Fusion	   cloning	   reaction.	   The	   In-­‐Fusion	   enzyme	   generates	   single-­‐
stranded	  regions	  of	  homology	  and	  then	  fuses	  the	  DNA	  insert	  to	  the	  vector.	  The	  added	  
advantage	  of	  In-­‐Fusion	  is	  that	  cloning	  is	  directional.	  
	  
Plasmid	  vectors	  were	  linearized	  by	  utilising	  specific	  restriction	  endonuclease	  enzymes.	  
The	  QIAquick	  gel	  extraction	  kit	   (Qiagen)	  was	  used	  to	  clean	  up	  amplified	  PCR	  product	  
and	   linearized	   plasmids.	   To	   prepare	   the	   In-­‐Fusion	   cloning	   reaction,	   the	   linearized	  
plasmid	  and	  insert	  were	  typically	  mixed	  together	  at	  an	  approximately	  	  1:1	  molar	  ratio	  
in	   a	   10µL	   reaction	   that	   contains	   1µL	   In-­‐Fusion	   enzyme	   and	   its	   appropriate	   buffer.	  
Reactions	  were	  carried	  out	  at	  37°C	  for	  15min,	  followed	  by	  15min	  at	  50°C.	  	  
	  
2.2.	  Site-­‐directed	  mutagenesis	  
In	  order	  to	  create	  mutations	  or	  deletions	  at	  specific	  sites	  in	  the	  plasmids,	  a	  PCR-­‐based	  
site-­‐directed	  mutagenesis	  method	  was	  used.	  The	  number	  of	  PCR	  cycles	  was	  kept	   low	  




PCR.	   To	   compensate,	   a	   higher	   starting	   amount	   of	   template	   plasmid	   DNA	   was	   used	  
(typically	   1μg).	   The	   sense	   and	   antisense	   primers	   were	   designed	   to	   anneal	   to	  
complementary	   strands	   of	   the	   same	   circular	   template	   plasmid	   DNA,	   to	   enable	   the	  
targeted	  modification.	  Additionally,	  the	  first	  16	  nucleotides	  of	  each	  primer	  were	  each	  
other’s	  reverse	  complement,	  to	  permit	  the	  re-­‐circularization	  of	  the	  linear	  PCR	  product	  
by	   In-­‐Fusion.	   The	   PCR	   reaction	  was	   performed	   using	   Advantage	   HD	   polymerase	  mix	  
(Clontech/Takara	  Bio)	  with	  ~1µg	  of	  DNA	  template,	  10µM	  of	  each	  primer	  and	  2.5mM	  of	  
each	  dNTP.	  Following	  PCR,	  the	  reaction	  was	  subjected	  to	  DpnI	  digestion	  overnight	  at	  
37°C	   to	   digest	   the	  methylated	   template	   DNA.	   The	   linearized	   PCR	   product	   was	   then	  
purified	  using	  the	  QIAquick	  gel	  extraction	  kit	  (Qiagen)	  and	  circularized	  by	  In-­‐Fusion.	  
	  
2.3.	  Bacterial	  transformation	  and	  selection	  	  
Bacterial	   transformation	   was	   carried	   out	   with	   NEB	   5-­‐alpha	   competent	   cells	   (New	  
England	   Biolabs).	   Briefly,	   frozen	   competent	   cells	   were	   thawed	   on	   ice	   followed	   by	  
incubation	  with	  the	  DNA	  on	  ice	  for	  30min.	  Cells	  were	  heat-­‐shocked	  for	  45s	  at	  42°C	  and	  
placed	   on	   ice	   for	   1min.	   To	   allow	   expression	   of	   the	   antibiotic	   resistance,	   cells	   were	  
resuspended	  in	  450µL	  super	  optimal	  broth	  with	  glucose	  (SOC)	  medium	  and	  incubated	  
at	  37°C	  for	  1h	  with	  shaking.	  The	  cell	  culture	  was	  then	  plated	  onto	  Luria	  Broth	  (LB)	  agar	  
plates	   supplemented	   with	   100µg/mL	   ampicillin.	   Colonies	   were	   picked	   and	   grown	   in	  
5mL	   LB	   culture	   containing	   100µg/mL	   ampicillin	   and	   incubated	   at	   37°C	   overnight.	  
Plasmid	  DNA	  was	  extracted	  and	  purified	  from	  the	  overnight	  culture	  using	  the	  Wizard	  
Plus	   SV	   Minipreps	   DNA	   purification	   system	   (Promega)	   and	   analysed	   by	   diagnostic	  





2.4.	  Parasite	  maintenance	  
P.	  berghei	  ANKA	  clone	  234	  parasites	  were	  maintained	  as	  cryopreserved	  stabilates	  or	  by	  
mechanical	   blood	   passage	   and	   mosquito	   transmission.	   For	   cryopreservation	  
parasitized	  blood	  was	  mixed	  with	  an	  equal	  volume	  of	  cryopreservation	  solution	  (20%	  
dimethyl	  sulfoxide	  (DMSO),	  10%	  fetal	  bovine	  serum	  (FBS),	  70%	  RPMI	  1640)	  and	  slowly	  
frozen	   to	   -­‐80°C	   before	   transfer	   to	   liquid	   nitrogen	   for	   long-­‐term	   storage.	   As	   rodent	  
hosts,	   CD1	   mice	   (typically	   20-­‐25g,	   female)	   were	   used.	   Animals	   were	   infected	   by	  
intraperitoneal	   (i.p.)	   injection	   of	   fresh	   or	   cryopreserved	   parasitized	   blood,	   or	   by	  
sporozoite-­‐infected	   mosquito	   bites.	   The	   levels	   of	   infection	   were	   monitored	   and	  
observed	  by	  light	  microscopic	  examination	  of	  Giemsa-­‐stained	  thin	  blood	  films.	  	  
	  
2.5.	  Mosquito	  maintenance	  and	  infection	  	  
A.	  stephensi	  mosquitoes	  were	  maintained	  in	  cages	  at	  ~27°C,	  at	  high	  relative	  humidity,	  
under	  a	  12h	  light/dark	  cycle	  and	  fed	  on	  10%	  glucose	  solution.	  Adult	   insects	  were	  fed	  
on	   human	   blood	   in	   membrane	   feeders	   (kept	   at	   37°C)	   twice	   a	   week	   to	   induce	   egg	  
laying.	  Naïve	  mosquitoes	  were	   infected	  with	  P.	  berghei	  by	   feeding	  on	  anaesthetized,	  
gametocytaemic	   mice.	   For	   optimal	   development	   of	   the	   parasite,	   experimental	  
mosquitoes	  were	  kept	  at	  19-­‐21°C	  at	  high	  relative	  humidity	  and	  with	  10%	  glucose	   for	  
feeding.	   Transmission	   of	   sporozoites	   (biteback)	   was	   carried	   out	   with	   sporozoite-­‐
infected	  mosquitoes	  (about	  three	  weeks	  post-­‐infection)	  and	  naïve	  mice.	  	  
	  
2.6.	  Ookinete	  culture	  and	  purification	  	  
To	   induce	   reticulocytosis,	   mice	   were	   treated	   with	   phenylhydrazine	   (~10µL/g	   body	  
weight	  of	  a	  6mg/mL	  solution	  in	  PBS)	  followed	  by	  injection	  of	  107–108	  parasites	  three	  
days	  later.	  Three	  days	  following	  infection,	  parasitized	  blood	  was	  harvested	  and	  mixed	  




glutamine,	  2g/L	  sodium	  bicarbonate,	  1/100	  volume	  of	  10,000u/mL	  penicillin/10mg/mL	  
streptomycin	   solution	   (Gibco),	   50mg/L	   hypoxanthine,	   100mM	   xanthurenic	   acid	   and	  
20%	   FBS,	   pH7.4).	   Cultures	   were	   incubated	   at	   19-­‐21°C	   for	   18-­‐24h	   to	   allow	   ookinete	  
development.	  	  
	  
For	  ookinete	  purification,	  cells	  were	  collected	  by	  centrifugation	  at	  800xg	   for	  5min	  at	  
4°C,	   the	  pellet	   resuspended	   in	   ice-­‐cold	  0.17M	  ammonium	  chloride	  and	   incubated	  on	  
ice	  for	  30min	  to	  lyse	  the	  unparasitized	  RBCs.	  Parasites	  were	  collected	  by	  centrifugation	  
at	   800xg	   for	   10min	   at	   4°c	   with	   low	   deceleration	   and	   washed	   twice	   in	   PBS	   (500xg	  
centrifugation).	  The	  number	  of	  ookinetes	  was	  estimated	  by	  haemocytometer	  count.	  	  
	  
2.7.	  Generation	  of	  genetically	  modified	  parasite	  lines	  
For	   the	   generation	   of	   transgenic	   P.	   berghei	   parasite	   lines,	   purified	   schizonts	   were	  
transfected	   followed	   by	   drug	   selection	   and	   limiting	   dilution	   cloning,	   according	   to	  
described	   methods	   (Janse	   et	   al.,	   2006).	   To	   achieve	   double	   homologous	   crossover	  
recombination,	   targeting	  vectors	  were	  digested	  with	  specific	  enzymes	  to	   remove	  the	  
backbone	  of	  the	  vector	  and	  column	  purified.	  	  
	  
Blood	  was	  harvested	  from	  P.	  berghei-­‐infected	  mice	  with	  parasitaemia	  between	  1%	  and	  
4%,	   and	   added	   to	   100mL	   filter-­‐sterilized	   schizont	   culture	   medium	   (RPMI	   1640	  
containing	  20mM	  Hepes	  and	  L-­‐glutamine	  (Sigma	  R73880),	  0.8g/L	  sodium	  bicarbonate,	  
1/200	  volume	  of	  neomycin	  solution	  (Sigma	  N1142)	  and	  20%	  FBS,	  pH7.2).	  The	  culture	  
was	   equilibrated	   with	   a	   5%	   CO2,	   10%	   O2,	   85%	   N2	   gas	  mixture	   (BOC)	   and	   the	   flask	  
sealed	  airtight,	  followed	  by	  incubation	  at	  36°C	  with	  gentle	  shaking	  (60–80	  revolutions	  
per	  minute)	   for	  20h.	  Schizonts	  were	  purified	  by	  centrifugation	   for	  30min	  at	  500xg	  at	  
room	   temperature	   (no	  brake)	  on	  a	  50%	  Histodenz	   (in	  PBS)	   cushion	   (100%	  Histodenz	  




EDTA).	  The	  interface	  layer	  containing	  the	  schizonts	  was	  harvested	  and	  centrifuged	  for	  
8min	  at	  450xg.	  The	  schizont	  pellet	  was	  gently	  resuspended	   in	  complete	  nucleofector	  
solution	  (Basic	  Parasite	  Nucleofector	  kit,	  Amaxa),	  and	  for	  each	  transfection	  100µL	  was	  
mixed	  with	  DNA	  (1-­‐5µg	  in	  10-­‐12µL	  dH2O	  or	  TE	  buffer).	  Electroporation	  was	  carried	  out	  
with	   programme	   U-­‐033	   of	   the	   NucleofectorTM	   II	   Device	   (Amaxa).	   Directly	   post	  
electroporation,	   approximately	   250µL	   of	   naïve	   blood	   (previously	   incubated	   at	   37°C)	  
was	   added	   to	   the	   parasites,	   and	   the	  mixture	  was	   kept	   at	   37°C	   for	   30min	   to	   permit	  
merozoite	   invasion	  of	   naive	  RBCs.	   Finally,	   the	  parasite/RBC	  mixture	  was	   injected	   i.p.	  
into	  naïve	  mice.	  	  
	  
One	  day	  after	  transfection,	  pyrimethamine	  selection	  was	  started	  (supplied	  in	  drinking	  
water	   at	   a	   dose	   equal	   to	   10mg/kg/day)	   until	   patent	   parasitaemia	   was	   observed	  
(usually	  7-­‐10	  days	  post-­‐inoculation).	  When	  parasitaemia	   reached	  around	  1%,	   limiting	  
dilution	   cloning	  was	   carried	  out.	   Parasites	  were	  diluted	   in	  RPMI	   to	   an	  estimated	  0.3	  
parasites/inoculum,	   and	   typically	   10	   naive	   animals	  were	   inoculated	   by	   i.p.	   injection.	  
Infected	  mice	  were	   identified	  one	  week	   later	  by	  Giemsa	  staining	  of	   thin	  blood	   films.	  
Clonal/isogenic	   parasite	   populations	   were	   checked	   by	   diagnostic	   PCR	   for	   correct	  
integration	  of	  the	  transgene	  in	  the	  target	  locus,	  and	  for	  the	  absence	  of	  the	  unmodified	  
target	  allele.	  
	  
2.8.	  Western	  blot	  analysis	  
Protein	  samples	  were	  run	  through	  pre-­‐cast	  NuPAGE	  Bis-­‐Tris	  SDS	  gels	  (Invitrogen)	  using	  
an	  XCell	  SureLock	  Mini-­‐Cell	  system	  (Invitrogen).	  Before	  loading,	  samples	  were	  heated	  
at	  70°C	  for	  10min	   in	  the	  presence	  or	  absence	  of	  1%	  reducing	  agent	   (Invitrogen).	  The	  
fractionated	   protein	   was	   then	   transferred	   onto	   a	   polyvinylidene	   fluoride	   (PVDF)	  




blocked	  for	  1h	  at	  room	  temperature	  in	  PBS	  supplemented	  with	  0.1%	  Tween	  20	  and	  5%	  
skimmed	  milk.	  Membranes	  were	   incubated	  either	  overnight	  at	  4°C	  or	  for	  1h	  at	  room	  
temperature	  with	  specific	  antibody	  at	  the	  appropriate	  dilution	  (outlined	  in	  table	  2.1).	  
Typically	  horse	   radish	  peroxidase	   (HRP)	  conjugated	  antibodies	  were	  used	  to	  visualise	  
the	  signal	  by	  chemiluminescence,	  using	  ECL	  Western	  Blotting	  Substrate	  (Pierce)	  and	  X-­‐
ray	  film	  (CL-­‐XPosure™	  Film,	  Pierce).	  
Table	  2.1.	  Antibodies	  and	  concentrations	  used	  for	  western	  blot	  analysis.	  
Primary	   goat	   polyclonal	   antibody	   to	   GFP	  
conjugated	   to	   horseradish	   peroxidase	  
(Abcam	  ab6663)	  
1:5000	  
Anti-­‐Pbs21	   monoclonal	   antibody	   (13.1,	  
Tirawanchai	  and	  Sinden,	  1990)	  
1:5000	  
Horse	   radish	   peroxidase	   conjugated	   goat	  
anti-­‐mouse	  IgG	  (Sigma	  A4461)	  
1:5000	  
	  
2.9.	  Light	  microscopy	  	  
Standard	  light	  microscopic	  analysis	  of	  parasite	  and	  mosquito	  samples,	  Giemsa-­‐stained	  
blood	   films	   and	   haemocytometer	   counts	   were	   undertaken	   using	   an	   Olympus	   CX41	  
microscope.	   An	   Olympus	   SZ	   microscope	   was	   used	   for	   mosquito	   dissections.	   For	  
assessment	  of	  fluorescence,	  live	  or	  fixed	  parasite	  samples	  were	  assessed,	  and	  images	  
captured,	   on	   a	   Zeiss	   LSM510	   inverted	   confocal	  microscope,	   or	   on	   a	   Zeiss	  Axioplan-­‐2	  
fluorescent	  microscope	  with	  Retiga	  2000R	  CCD	  camera	  system	  and	  Volocity	  software.	  
	  
2.10	  Sporozoite	  size	  measurements	  
Images	  of	  individual	  midgut	  sporozoites	  were	  captured	  by	  microscopy	  on	  Zeiss	  LSM510	  
inverted	  laser	  scanning	  confocal	  microscope.	  Using	  the	  Zeiss	  LSM	  image	  browser	  
software,	  the	  circumference	  was	  measured	  of	  the	  sporozoite	  was	  measured.	  This	  gave	  
a	  value	  equivalent	  to	  the	  occupied	  surface	  area,	  and	  was	  calculated	  as	  a	  measure	  of	  




2.11	  Osmotic	  shock	  and	  viability	  assay	  
Unpurified	  ookinetes	  were	  subjected	  to	  a	  hypo-­‐osmotic	  shock	  of	  0.5	  ×	  normal	  osmotic	  
strength	  through	  adding	  an	  equal	  volume	  of	  water.	  Sporozoites	  were	  released	  from	  
oocyst-­‐infected	  midguts	  at	  15	  days	  post-­‐infection	  in	  a	  Dounce	  homogeniser,	  and	  were	  
subjected	  to	  0.33	  ×	  normal	  osmotic	  strength	  by	  adding	  two	  equal	  volumes	  of	  water.	  
After	  5	  minutes,	  normal	  osmotic	  conditions	  were	  restored	  by	  adding	  an	  appropriate	  
amount	  of	  10	  ×	  PBS.	  	  
Cell	  viability	  was	  recorded	  using	  fluorescence	  microscopy	  in	  the	  presence	  of	  0.5%	  
propidium	  iodide	  and	  1%	  Hoechst	  33258.	  Ookinetes	  whose	  nuclei	  stained	  positive	  for	  
both	  propidium	  iodide	  and	  Hoechst	  were	  scored	  as	  non-­‐viable,	  whereas	  ookinetes	  
whose	  nuclei	  stained	  positive	  only	  for	  Hoechst	  were	  scored	  as	  viable.	  Values	  were	  
normalized	  to	  100%	  viability	  in	  untreated	  cells.	  
2.12	  Motility	  assay	  
Aliquots	  of	  unpurified	  ookinete	  cultures	  were	  added	  to	  equal	  volumes	  of	  Matrigel	  (BD	  
Biosciences)	  on	  ice,	  mixed	  thoroughly,	  placed	  onto	  a	  microscope	  slide,	  and	  covered	  
with	  a	  cover	  slip.	  After	  sealing	  with	  nail	  varnish,	  the	  Matrigel	  was	  allowed	  to	  set	  at	  
room	  temperature	  for	  30	  min	  before	  analysis.	  Sporozoites	  were	  gently	  released	  from	  
around	  20	  salivary	  glands	  in	  200	  μL	  RPMI	  medium	  in	  a	  Dounce	  homogenizer	  on	  ice.	  
Following	  addition	  of	  an	  equal	  volume	  of	  RPMI	  supplemented	  with	  20%	  foetal	  bovine	  
serum,	  the	  sporozoites	  were	  transferred	  to	  an	  Eppendorf	  tube	  and	  collected	  by	  
centrifugation	  in	  a	  swing-­‐out	  rotor	  for	  10	  min	  at	  1,000	  ×	  g	  at	  4°C,	  followed	  by	  removal	  
of	  excess	  supernatant.	  	  
Aliquots	  of	  resuspended	  sporozoites	  were	  mixed	  with	  an	  equal	  volume	  of	  Matrigel	  on	  




the	  Matrigel	  was	  allowed	  to	  set	  at	  room	  temperature	  for	  30	  min	  before	  analysis.	  Cells	  
were	  examined	  and	  time-­‐lapse	  images	  taken	  on	  a	  Zeiss	  Axioplan	  II	  microscope.	  Movies	  
were	  analysed	  with	  ImageJ	  using	  the	  Manual	  Tracking	  plugin.	  Statistical	  analysis	  was	  
carried	  out	  using	  ANOVA	  and	  Tukey's	  multiple	  comparison.	  
2.13	  Bioinformatics	  tools	  	  
The	   program	   PrDOS	   (Ishida	   and	   Kinoshita,	   2007)	   was	   used	   to	   look	   at	   the	   disorder	  
probability	   of	   proteins.	   The	   program	   Quick2D	   (MPI	   Bioinformatics	   Toolkit,	  
https://toolkit.tuebingen.mpg.de)	  was	  used	  to	  make	  secondary	  structure	  predictions.	  
2.14	  Protein	  expression	  	  
E.	   coli	   strain	   BL21*(DE3)	   was	   used	   for	   protein	   expression.	   This	   strain	   is	   suitable	   for	  
protein	  expression	  as	  it	  is	  deficient	  in	  Lon	  and	  OmpT	  proteases.	  BL21*(DE3)	  cells	  were	  
co-­‐transformed	   with	   pRARE2	   plasmid	   that	   provides	   rare	   amino	   acids	   to	   enhance	  
protein	   synthesis,	   which	   was	   selected	   for	   with	   100µg/mL	   chloramphenicol.	   When	  
transformed	   with	   a	   plasmid	   containing	   a	   T7	   inducible	   promotor	   region,	   protein	  
expression	  can	  be	  induced	  through	  the	  addition	  of	  IPTG.	  	  
BL21	   cells	  were	   co-­‐transformed	  with	   the	   pETM6T1	   and	   pRARE2	   constructs	   of	   choice	  
and	   selected	  with	  100µL/mL	  kanamycin	  and	   chloramphenicol.	   Typically,	   transformed	  
bacteria	  were	  grown	   in	  a	   starter	   culture	  with	  200mL	  sterile	   LB	  broth	  with	  100µL/mL	  
kanamycin	   and	   chloramphenicol,	   and	   10mL	   of	   the	   starter	   culture	   was	   added	   to	  
separately	  prepared	  sterile	  1L	  LB	  flasks.	  Flasks	  were	  shaken	  at	  200rpm	  at	  37°C	  for	  ~4	  
hours,	  until	  an	  OD600	  of	  0.6	  -­‐	  0.8	  was	  reached.	  This	  OD600	  indicates	  that	  the	  bacteria	  are	  
entering	  log	  phase	  of	  growth,	  which	  has	  been	  shown	  to	  be	  the	  optimal	  time	  to	  induce	  




were	  resuspended	  in	  10mL	  of	  cold	  lysis	  buffer	  (150mM	  NaCl,	  50mM	  Tris-­‐HCl,	  pH8)	  and	  
stored	  at	  -­‐80°C.	  	  
2.15	  Protein	  purification	  	  
To	   release	   protein	   from	   bacterial	   cells,	   pellets	   were	   defrosted	   in	   a	   20%	   ethanol-­‐ice	  
bath.	  Once	  defrosted,	  the	  cells	  were	  sonicated	  at	  100%	  amplitude	  in	  2	  second	  pulses	  
for	  2	  minutes	  on	  ice	  to	  ensure	  heat	  dissipation.	  This	  was	  repeated	  3	  times	  before	  cells	  
were	  further	   lysed	  using	  an	  Emulsiflex	  C3	  with	  a	  pressure	  beating	  around	  10,000	  psi.	  
Both	  processes	  ensured	  that	  bacterial	  cells	  were	  sufficiently	  lysed	  to	  release	  expressed	  
protein.	   The	   lysate	   was	   ultracentrifuged	   for	   1	   hour	   at	   20,000rpm	   to	   separate	   the	  
soluble	  and	   insoluble	   fractions.	   The	   insoluble	   fraction	  was	  discarded	  and	   the	   soluble	  
fraction	  was	  added	   to	  an	  equilibrated	  batch	  column	  containing	  2mL	  of	  TALON	  metal	  
affinity	  resin,	  and	  was	  incubated	  at	  4°C	  rolling	  for	  at	  least	  1	  hour.	  This	  immobilizes	  the	  
His-­‐tagged	  NusA	  protein.	  The	  column	  was	  rinsed	  5	  times	  with	  wash	  buffer	  A	  (150mM	  
NaCl,	  50mM	  Tris-­‐HCl,	  pH8)	  to	  remove	  unbound	  proteins.	  The	  batch-­‐column	  was	  then	  
rinsed	   with	   wash	   buffer	   B	   (150mM	   NaCl,	   50mM	   Tris-­‐HCl	   pH8,	   20mM	   imidazole)	   to	  
elute	  any	  non-­‐specific	  protein	  that	  may	  have	  bound	  due	  to	  a	  negative	  charge.	  Protein	  
was	  eluted	  off	  the	  column	  with	  10mL	  elution	  buffer	  (150mM	  NaCl,	  50mM	  Tris-­‐HCl	  pH8,	  
500mM	  imidazole).	  The	  eluate	  was	  incubated	  overnight	  at	  4°C	  with	  TEV	  protease	  at	  a	  
final	   concentration	   of	   0.1mg/mL,	   whilst	   being	   dialysed	   against	   wash	   buffer	   A	   to	  
remove	   imidazole.	  The	  protein-­‐TEV	  solution	  was	  then	  added	  to	  a	  HiTrap	  Q	  Fast	  Flow	  
anion	  exchange	  column	  (GE	  Healthcare),	  equilibrated	  with	  5	  column	  volumes	  of	  buffer	  
A	  (50mM	  Tris-­‐HCl	  pH8),	  5	  column	  volumes	  of	  charge	  buffer	  (1M	  NaCl,	  50mM	  Tris-­‐HCl	  
pH8)	   and	   then	   10	   column	   volumes	   of	   buffer	   A.	   The	   pH	   of	   the	   buffer	   was	   set	   at	   8,	  




around	  pH5.	  Accordingly,	  at	  pH8	  the	  NusA	  and	  alveolin	  portions	  of	  the	  fusion	  protein	  
were	  expected	  to	  behave	  very	  differently	  on	  an	  ion	  exchange	  column	  facilitating	  their	  
separation.	  On	  occasion	  ion	  exchange	  was	  used	  in	  conjunction	  with	  a	  HisTrap	  Fast	  Flow	  
column	  (GE	  Healthcare)	  
If	  desired,	  proteins	  were	  purified	  and	  concentrated	  by	  size	  exclusion	  chromatography,	  
using	   a	   Superdex	   75	   (s75)	   column	   (GE	   Healthcare).	   Protein	   was	   loaded	   on	   to	   the	  
column	  using	  an	  ÄKTA	  device.	  The	  s75	  column	  is	  efficient	   in	  separating	  proteins	  with	  




















Structure-­‐function	  analysis	  of	  the	  alveolin	  IMC1b	  	  
	  





Alveolins	  are	  grouped	  by	  virtue	  of	  possessing	  conserved	  domains	  made	  up	  of	  tandem	  
repeat	  sequences	  of	  a	  12	  amino	  acid	  periodicity	  (Al-­‐Khattaf	  et	  al.,	  2015).	  The	  presence	  
of	  such	  modules	  in	  all	  alveolin	  proteins	  suggests	  that	  they	  carry	  the	  potential	  filament-­‐
forming	   properties	   of	   these	   molecules.	   Besides	   these	   shared	   modules,	   a	   subset	   of	  
alveolins	  with	  demonstrated	   roles	   in	  motility	   (i.e.	   IMC1a,	   IMC1b	  and	   IMC1h)	  possess	  
additional	  conserved	  domains	  that	  are	  structurally	  unrelated	  to	  the	  ‘alveolin’	  module	  
or	  any	  other	  known	  protein	  domains.	  The	  roles	  of	  the	  latter	  in	  protein	  function	  remain	  
poorly	  understood.	  To	  address	  this	  question,	  and	  to	  gain	  a	  better	  understanding	  of	  the	  
contribution	   of	   different	   conserved	   domains	   in	   alveolin	   function	   more	   generally,	   a	  
series	   of	   structure-­‐function	   analyses	   of	   the	   ookinete-­‐expressed	   alveolin	   IMC1b	  were	  
carried	  out.	  	  
IMC1b	  contains	  a	  type	  1	  alveolin	  domain	  (ALV1),	  a	  type	  2	  alveolin	  domain	  (ALV2)	  and	  a	  
third,	   structurally	   unrelated	   conserved	   domain	   (ALV3)	   (Fig.	   3.2A).	   IMC1b	  has	   a	   close	  
structural	  paralogue	  named	  IMC1a,	  which	  is	  expressed	  in	  sporozoites	  where	  it	  carries	  
out	   functionally	   equivalent	   roles	   (Khater	  et	  al.,	   2004).	   Because	   IMC1b	   is	   dispensable	  
for	   blood	   stage	   parasite	   development,	   its	   coding	   sequence	   can	   be	   successfully	  
disrupted	   (Tremp	   et	   al.,	   2008).	   This	   revealed	   that	   IMC1b	   null	   mutant	   (IMC1b-­‐KO)	  
parasites	   exhibit	   clear	   and	   measurable	   phenotypes	   with	   regards	   to	   ookinete	  
morphology,	   tensile	   strength	   and	   motility	   (Tremp	   et	   al.,	   2008).	   For	   these	   reasons,	  
IMC1b	   constituted	   a	   suitable	   alveolin	   for	   assessing	   the	   roles	   of	   different	   alveolin	  






3.2	  Materials	  &	  Methods	  
3.2.1	  Plasmid	  constructs	  	  
Plasmid	   pLP-­‐IMC1b/EGFP	   was	   previously	   constructed	   for	   the	   allelic	   replacement	   of	  
imc1b	   with	   a	   full-­‐length	   GFP-­‐tagged	   version	   via	   double	   crossover	   homologous	  
recombination	  (Tremp	  et	  al.,	  2008)	  (Fig	  3.1).	  This	  plasmid	  contains	  one	  HindIII	  site	  near	  
the	  start	  of	  the	  coding	  sequence	  (at	  amino	  acid	  position	  30)	  and	  a	  second	  HindIII	  site	  at	  
the	  IMC1b/GFP	  junction.	  Recombinant	  alveolin	  sequences	  were	  PCR	  amplified	  from	  P.	  
berghei	  genomic	  DNA	  with	  specific	  primers	  (Table	  3.1).	  PCR	  conditions	  were	  optimised	  
to	   reflect	   the	   primer	   sequences,	   with	   an	   annealing	   temperature	   of	   55	  ̊C	   and	   an	  
extension	  time	  of	  2	  minutes	  (1	  min	  per	  kb)	  for	  25	  cycles.	  	  PCR	  products	  encoding	  the	  
various	   IMC1b-­‐	   and	   IMC1a-­‐specific	   parts	   were	   introduced	   by	   In-­‐Fusion	   into	   HindIII-­‐
digested	   pLP-­‐IMC1b/EGFP	   (Fig.	   3.2A)	   giving	   rise	   to	   plasmids	   pLP-­‐IMC1b/ALV1,	   pLP-­‐
IMC1b/ALV2,	   pLP-­‐IMC1b/ALV3,	   pLP-­‐IMC1b/ALV1+2,	   pLP-­‐IMC1b/ALV1-­‐3	   and	   pLP-­‐
IMC1b/IMC1a.	  	  
Fig	  3.1	  The	  double	  homologous	  recombination	  strategy.	  The	  wildtype	  locus	  containing	  the	  innate	  5’UTR,	  imc1b	  and	  
3’UTR	  has	  a	  homologous	  sequence	  between	  the	  introduced	  mutant	  locus,	  that	  has	  attached	  to	  it	  a	  gfp	  reporter	  and	  
tgdhfr,	   a	   drug	   selectable	  marker.	  Upon	  DNA	   replication,	   a	   double	   strand	   break	   is	   introduced	   that	   allows	   for	   the	  
homologous	  flanking	  regions	  to	  doubly	  recombine,	  integrating	  the	  mutant	  locus	  in	  to	  the	  parasites	  genome.	  	  
	  
Plasmid	  pLP-­‐IMC1b/EGFP	  was	  used	  as	  the	  DNA	  template	  for	  a	  PCR-­‐based	  site	  directed	  
mutagenesis	  to	  remove	  sequences	  encoding	  specific	  domains	  of	  IMC1b,	  using	  specific	  




and	   the	   PCR	   fragment	   circularized	  by	   In-­‐Fusion,	   to	   give	   plasmids	   pLP-­‐IMC1bΔ1,	   pLP-­‐
IMC1bΔ2,	  pLP-­‐IMC1bΔ3	  and	  pLP-­‐IMC1bΔ1+2.	  
Table	  3.1.	  PCR	  primer	  sequences	  used	  to	  amplify	  IMC1b-­‐	  and	  IMC1a-­‐specific	  sequences	  
Region	  Amplified	  	   Forward	  Primer	  	   Reverse	  Primer	  	  









IMC1b	  ALV3	   ATGATCAATTAAGCTCAAAATATAGTCCTA
ACAATTTTTA TGATACTATACC  
GAGGGCCCCTAAGCTCTCTACTTT
GGCTTCACGTGG  














Table	  3.2.	  PCR	  primer	  sequences	  used	  in	  site-­‐directed	  mutagenesis	  to	  delete	  IMC1b-­‐specific	  sequences.	  
Region	  Deleted	   Forward	  Primer	  	   Reverse	  Primer	  	  



























Fig.	  3.2.	  DNA	  constructs	  for	  generating	  IMC1b/IMC1a	  knock-­‐in	  parasite	  lines.	  A)	  Predicted	  structure	  of	  the	  modified	  
imc1b	   alleles	   in	   the	   genetically	   modified	   parasite	   lines	   after	   transfection	   with	   various	   DNA	   constructs	   following	  
‘knock-­‐in’	  strategy	  1.	  The	  two	  alleles	  at	  the	  top	  depict	  those	  in	  the	  previously	  generated	  parasite	  lines	  IMC1b/EGFP	  
and	   IMC1b-­‐KO	   (Tremp	  et	  al.,	   2008).	  The	   relative	  positions	  of	  primers	  P1	  and	  P2	  are	   shown	   for	  amplification	  of	  a	  
1.2kb	   DNA	   fragment	   across	   the	   3’-­‐integration	   site.	   Sizes	   of	   domains	   are	   not	   to	   scale.	   B)	   PCR	   fragments	  
corresponding	  to	  the	  inserts.	  Sizes	  are	  shown	  on	  the	  right	  hand	  side.	  C)	  Double	  digestion	  of	  plasmids	  with	  KpnI	  and	  
SacII	  drops	  out	  an	  approximately	  3kb	  fragment	  corresponding	  to	  the	  plasmid	  backbone.	  
	  
3.2.2	  Transfection	  and	  genotyping	  	  
Prior	  to	  transfection,	  plasmids	  were	  doubly	  digested	  with	  KpnI	  and	  SacII	  to	  remove	  the	  
plasmid	  backbone	  (Fig	  3.2C),	  allowing	  targeting	  into	  the	  native	  imc1b	  locus	  by	  double	  
crossover	  homologous	   recombination.	  Correct	   integration	  of	   the	   recombinant	   alleles	  





and	  selectable	  marker	  genes	  into	  the	  imc1b	  locus	  was	  carried	  out	  by	  diagnostic	  PCR	  of	  
genomic	  DNA,	  with	  primer	  pair	  P1	  (TgDHFRCAS3’)	  (TCGTGGGCTACGTCCCGCAC)	  and	  
P2	   (IMC1b3’diag)	   (TGGTTATATTTTCATTTTGAATTAATAATATATG),	  or	  P3	   (TgDHFR-­‐
F)	   (AGAGGGGCATCGGCATCAAC)	   and	   P2,	   designed	   to	   PCR	   amplify	   across	   the	   3’-­‐
integration	   site.	   Diagnostic	   PCR	   across	   the	   5’-­‐integration	   site	   was	   achieved	   by	  
diagnostic	  PCR	  with	  primer	  pair	  P4	   (IMC1b5’diag)	   (CGCCGTTCTAAATCAACTGA)	  and	  
P5	   (EGFP-­‐R)	   (GTGCCCATTAACCATCACC),	   or	   P4	   and	   P6	   (IMC1b-­‐delta1-­‐R)	  
(CGTTGTGGTCTTTAATTTTATTTCC).	  





The	  first	  strategy	  for	  the	  structure-­‐function	  analysis	  of	  IMC1b	  was	  to	  generate	  a	  series	  
of	   genetically	  modified	  P.	   berghei	   parasite	   lines	   in	  which	   specific	   IMC1b	   domains	   C-­‐
terminally	  tagged	  with	  GFP,	  as	  well	  as	  the	  entire	  alveolin	  IMC1a	  tagged	  with	  GFP,	  were	  
introduced	  into	  the	  native	   imc1b	   locus	  by	  allelic	  replacement.	  This	  ‘knock-­‐in’	  strategy	  
effectively	  replaces	  the	  native	  IMC1b	  protein	  with	  the	  recombinant	  GFP-­‐tagged	  IMC1b	  
domain	  (or	  the	  alveolin	   IMC1a),	  allowing	  assessment	  of	  their	  ability	  to	  assemble	   into	  
the	  ookinete’s	  pellicle	  (looking	  at	  cortical	  GFP	  fluorescence),	  as	  well	  as	  their	  ability	  to	  
rescue	  the	  IMC1b	  knockout	  phenotypes	  (looking	  at	  cell	  shape,	  motility,	  tensile	  strength	  
and	  infectivity)	  in	  live	  parasites.	  	  
PCR	   amplification	   of	   the	   various	   parts	   of	   imc1b	   and	   imc1a	   with	   the	   specific	   primer	  
pairs	   (Table	   3.1)	   gave	   rise	   to	   DNA	   fragments	   of	   the	   expected	   sizes	   (Fig.	   3.2B).	  
Successful	  In-­‐Fusion	  cloning	  of	  these	  fragments	  into	  HindIII-­‐digested	  pLP-­‐IMC1b/EGFP	  
was	   verified	   by	   double	   digestion	   with	   KpnI	   and	   SacII,	   removing	   the	   3kb	   plasmid	  
backbone	  (Fig.	  3.2C).	  	  
Pyrimethamine	   resistant	   parasite	   populations	   were	   recovered	   7-­‐10	   days	   post-­‐
transfection,	  indicating	  that	  successful	  integration	  had	  occurred.	  This	  would	  result	  in	  a	  
series	   of	   parasite	   lines	   expressing	   recombinant	   imc1b	   loci	   as	   depicted	   in	   Fig.	   3.2A.	  
Successful	   integration	   was	   corroborated	   by	   diagnostic	   PCR	   across	   the	   3’	   integration	  
site	   with	   primers	   P1	   and	   P2	   (Fig.	   3.2A),	   which	   amplified	   a	   1.2kb	   fragment	   of	   the	  
expected	  size	  in	  all	  transfections	  (Fig.	  3.3A).	  Following	  this,	  ookinete	  cultures	  were	  set	  
up	   from	   the	   uncloned	   parasite	   populations	   to	   determine	   if	   GFP-­‐positive	   ookinetes	  
were	  present.	  Green	  fluorescence	  was	  observed	  in	  five	  out	  of	  the	  six	  transfections	  (Fig.	  




fluorescence,	   it	   was	   decided	   to	   sequence	   the	   corresponding	   DNA	   construct.	   This	  
revealed	  the	  presence	  of	  a	  frame	  shift	  in	  a	  stretch	  of	  adenine	  repeats	  within	  the	  open	  
reading	  frame,	  explaining	  why	  no	  GFP	  fluorescence	  was	  observed.	  	  
Given	  the	  positive	  assays	  for	  integration	  in	  the	  transfections,	  parasites	  were	  subjected	  
to	   a	   second	   round	   of	   drug	   selection	   to	   further	   enrich	   for	   parasites	   carrying	   the	  
integrated	   drug	   resistance	   gene,	   followed	   by	   limiting	   dilution	   cloning	   to	   isolate	  
isogenic	  populations	  of	  the	  transgenic	  parasite	  lines.	  Clonal	  parasite	  populations	  were	  
then	   harvested	   and	   tested	   again	   for	   integration	   using	   the	   same	   diagnostic	   PCR.	  
Surprisingly,	  clones	  of	  all	  the	  transfections	  tested	  negative	  for	   integration,	  suggesting	  
that	   they	   constituted	   parental	   parasites.	   Subsequent	   diagnostic	   PCR	   of	   the	   second	  
round,	   uncloned	   parasite	   populations	   indicated	   integration	   of	   the	   selectable	  marker	  
had	   diminished	   or	   was	   lost	   entirely	   (Fig.	   3.3C),	   pointing	   to	   a	   loss	   of	   parasites	   with	  
integrated	   resistance	   and	   explaining	   why	   dilution	   cloning	   only	   yielded	   parental	  
parasites.	   This	   trend	   continued	   after	   a	   third	   round	   of	   selection	   (data	   not	   shown).	  
Similar	   outcomes	   were	   obtained	   after	   a	   second	   and	   third	   set	   of	   independent	  
transfections	   followed	   by	   drug	   selection	   and	   dilution	   cloning	   (data	   not	   shown).	   This	  
was	   entirely	   unexpected	   as	   sequential	   rounds	   of	   drug	   selection	   should	   enrich	   the	  






Fig.	  3.3.	  Genotyping	  of	  strategy	  1	  transfections.	  A)	  Diagnostic	  PCR	  across	  the	  3’-­‐integration	  site	  from	  parasite	  
genomic	  DNA	  after	  first	  round	  of	  drug	  selection.	  A	  fragment	  of	  1.2kb	  diagnostic	  for	  integration	  is	  amplified	  in	  all	  
transfections.	  Genomic	  DNA	  from	  clonal	  parasite	  line	  IMC1b-­‐KO	  (Tremp	  et	  al.	  2008)	  was	  used	  as	  a	  positive	  control.	  
B)	  Confocal	  microscopy	  of	  ookinetes	  cultured	  from	  uncloned	  parasite	  populations	  after	  1	  round	  of	  drug	  selection.	  
Green	  fluorescent	  ookinetes	  are	  present	  in	  all	  but	  one	  transfection.	  C)	  Diagnostic	  PCR	  across	  the	  3’	  integration	  site	  
from	  parasite	  genomic	  DNA	  after	  second	  round	  of	  drug	  selection.	  The	  1.2kb	  fragment	  diagnostic	  for	  integration	  is	  
lost	  or	  reduced.	  
	  
The	  problems	  with	  the	  first	  approach	  led	  to	  a	  different	  strategy,	  in	  which	  the	  function	  
of	  IMC1b	  lacking	  specific	  domains	  was	  assessed,	  rather	  than	  assessing	  the	  function	  of	  
specific	  IMC1b	  domains	  as	  in	  approach	  1.	  Using	  this	  ‘domain	  knock-­‐out’	  approach,	  the	  




protein	   can	   no	   longer	   do	   when	   these	   modules	   are	   lacking.	   This	   strategy	   had	   been	  
successfully	   used	   in	   the	   Dessens	   laboratory	   to	   study	   the	   contribution	   of	   certain	  
conserved	   domains	   of	   the	   ookinete-­‐expressed	   crystalloid	   proteins	   LAP1	   and	   LAP3	  
(Carter	  et	  al.,	  2008,	  Tremp	  et	  al.,	  2017,	  Saeed	  et	  al.,	  2015).	  Whilst	   this	  method	  used	  
essentially	   the	   same	   allelic	   replacement	   strategy	   as	   the	   knock-­‐in	   strategy,	   the	  
sequences	  available	  for	  crossover	  recombination	  were	   longer,	   increasing	  the	  chances	  
of	  achieving	  stable	  integration.	  
Successful	   site-­‐directed	   mutagenesis	   of	   the	   parental	   plasmid	   to	   generate	   the	   four	  
‘domain	   knockout’	   constructs	   was	   verified	   by	   diagnostic	   HindIII	   digest	   (Fig.	   3.4A).	  
HindIII	  drops	  out	  the	  entire	   imc1b	  coding	  sequence	  (bar	  the	  first	  30	  amino	  acids)	  and	  
this	   fragment	   is	   reduced	   in	   size	   by	   the	   corresponding	   domain	   deletions	   in	   the	   four	  
different	   constructs	   (Fig.	   3.4A).	   Selected	   plasmids	   were	   successfully	   doubly-­‐digested	  
with	  KpnI/SacII	  to	  remove	  the	  plasmid	  backbone,	  followed	  by	  transfection	  into	  purified	  
schizonts.	  This	  would	  result	  in	  a	  series	  of	  parasite	  lines	  expressing	  recombinant	  imc1b	  





Fig.	   3.4.	   Strategy	   2	   predicted	   modified	   alleles.	   A)	   Diagnostic	   HindIII	   digest	   of	   plasmids	   pLP-­‐IMC1b/EGFP,	   pLP-­‐
IMC1bΔ1,	  pLP-­‐IMC1bΔ2,	  pLP-­‐IMC1bΔ3	  and	  pLP-­‐IMC1bΔ1+2.	  Note	  the	  sizes	  of	  the	  HindIII	   fragment	  corresponding	  
to	   the	   IMC1b	   coding	   sequence	   differ	   with	   respect	   to	   the	   introduced	   domain	   deletions.	   DNA	   fragment	   sizes	   are	  
indicated	  on	   the	   right	  hand	   side.	  B)	  Predicted	   structure	  of	   the	  modified	   imc1b	   alleles	   in	   the	  genetically	  modified	  
parasite	  lines	  after	  transfection	  with	  various	  DNA	  constructs	  following	  ‘domain	  deletion’	  strategy	  2.	  The	  allele	  at	  the	  
top	  depicts	  that	  in	  the	  previously	  generated	  parasite	  line	  IMC1b/EGFP	  (Tremp	  et	  al.,	  2008).	  The	  relative	  positions	  of	  
primers	  P1-­‐P6	  are	  indicated.	  Sizes	  of	  domains	  are	  not	  to	  scale.	  
	  
A	   first	   series	   of	   transfections	   resulted	   in	   drug-­‐resistant	   parasite	   populations	   for	  
IMC1bΔ1	  and	  IMC1bΔ3	  only	  (2	  out	  of	  4).	  Diagnostic	  PCR	  across	  the	  3’-­‐integration	  site	  
with	   primers	   P3	   and	   P2	   (Fig.	   3.4B)	   gave	   rise	   to	   a	   2.9kb	   fragment	   in	   the	   IMC1bΔ1	  
transfection	   (Fig.	  3.5A),	   indicating	   that	   integration	  had	  occurred.	  This	  was	   supported	  
by	   diagnostic	   	   PCR	   across	   the	   5’-­‐integration	   site	   with	   primers	   P4	   and	   P5	   (Fig.	   3.4B)	  
resulting	   in	  a	  product	  of	  2.2kb	   in	   the	  control	  parasite	   (IMC1b/GFP),	  and	  a	  somewhat	  
smaller	  product	   in	   the	   IMC1bΔ1	   transfection(Fig.	  3.5A),	   indicating	   that	   the	   sequence	  
encoding	   domain	   1	   was	   indeed	   lacking.	   However,	   following	   dilution	   cloning,	   all	   the	  
clones	   obtained	   (7	   in	   7)	   possessed	   a	   full-­‐length	   imc1b::gfp	   allele,	   as	   is	   present	   in	  




a	  reverse	  primer	  closer	  to	  domain	  1	  (primer	  P6,	  Fig.	  3.4B)	  indicated	  that	  a	  mixture	  of	  
parasites	  were	   in	   fact	  present,	   the	  majority	  of	  which	  possessed	  the	  full-­‐length	   imc1b	  
coding	  sequence	  (Fig.	  3.5C).	  
	  
Fig.	  3.5.	  Genotyping	  of	  strategy	  2	  transfections	  series	  1.	  A)	  Diagnostic	  PCR	  with	  primer	  pairs	  P2/P3	  and	  P4/P5	  for	  
integration	  across	  the	  3’-­‐	  and	  5’-­‐integration	  sites,	  respectively,	  of	  gDNA	  from	  IMC1bΔ1	  and	  IMC1bΔ3	  transfections.	  
IMC1b/GFP	   is	  used	  as	  a	  positive	  control,	  while	  parental	  parasites	  are	  used	  as	  negative	  control.	  B)	  Clonal	  parasite	  
populations	  after	  dilution	  cloning	  of	  IMC1bΔ1	  possess	  full-­‐length	  imc1b::gfp	  alleles.	  IMC1b/GFP	  is	  used	  as	  a	  positive	  
control.	  C)	  Diagnostic	  PCR	  of	  transfection	  IMC1bΔ1	  with	  primer	  pair	  P4/P6,	  showing	  a	  doublet	  amplified	  from	  full-­‐








In	  a	  second	  series	  of	  transfections,	  drug	  resistant	  parasites	  were	  obtained	  for	  all	  four	  
transfections,	   but	   only	   IMC1bΔ1	   and	   IMC1bΔ3	   populations	   appeared	   to	   have	  
integration	   according	   to	   diagnostic	   PCR	   (Fig.	   3.6A).	   In	   this	   case,	   however,	   diagnostic	  
PCR	  across	  the	  5’-­‐integration	  site	  failed	  to	  support	  integration	  (Fig.	  3.6B)	  and,	  following	  
dilution	  cloning,	  only	  clones	  with	  an	  unmodified	  imc1b	  allele	  were	  obtained	  (Fig.	  3.6C).	  
A	   third	   series	   of	   transfections	   resulted	   in	   drug-­‐resistant	   parasites	   in	   three	  
transfections,	  but	  no	  integration	  was	  observed	  in	  any	  (Fig.	  3.6D).	  
	  
Fig.	   3.6.	   Genotyping	   of	   strategy	   2	   transfections	   series	   2	   and	   3.	   A)	   Diagnostic	   PCR	   with	   primer	   pairs	   P2/P3	   for	  
integration	   across	   the	   3’-­‐integration	   sites	   of	   gDNA	   from	   IMC1bΔ1,	   IMC1bΔ2,	   IMC1bΔ3	   and	   IMC1bΔ1+2	  
transfections	   series	   2.	   IMC1b/GFP	   is	   used	   as	   a	   positive	   control.	   B)	   Diagnostic	   PCR	   with	   primer	   pair	   P4/P5	   for	  
integration	  across	  5’-­‐integration	  sites	  of	  gDNA	  from	  IMC1bΔ1	  and	  IMC1bΔ3	  transfections.	  IMC1b/GFP	  is	  used	  as	  a	  
positive	   control.	   C)	  Diagnostic	  PCR	  with	  primer	  pair	  P2/P4	  of	   clonal	  parasite	  populations	  after	  dilution	   cloning	  of	  
IMC1bΔ3	   and	   IMC1bΔ3	   amplifies	   an	   approximately	   3.0kb	   fragment	   indicative	   of	   the	   unmodified	   imc1b	   allele.	   D)	  
Diagnostic	   PCR	   with	   primer	   pairs	   P2/P3	   for	   integration	   across	   the	   3’-­‐integration	   sites	   of	   gDNA	   from	   IMC1bΔ1,	  






IMC1b	  is	  expressed	  exclusively	  in	  the	  ookinete	  life	  cycle	  stage	  of	  the	  parasite.	  Through	  
tagging	   and	   knockout	   of	   IMC1b,	   previous	   studies	   have	   shown	   that	   the	   full	   length	  
protein	   localises	   to	   the	   pellicle	   of	   the	   parasite,	   consistent	   with	   its	   predicted	  
cytoskeletal	   role	   as	   an	   intermediate	   filament	   protein	   (Tremp	   et	   al.,	   2008).	  
Furthermore,	   knockout	   of	   IMC1b	   gives	   rise	   to	   misshapen	   ookinetes	   with	   reduced	  
tensile	   strength,	  motility	   and	   infectivity	   that	   can	  be	  quantified	   through	   a	   number	   of	  
established	   assays	   (Tremp	   et	   al.,	   2008).	   IMC1b	   and	   its	   structural	   paralogue	   IMC1a	  
possess	  a	  conserved	  type	  1	  (ALV1)	  and	  type	  2	  (ALV2)	  domain,	  as	  well	  as	  an	  unrelated	  
conserved	  domain	  near	  the	  C-­‐terminus	  (ALV3).	  Although	  the	  first	  two	  domains	  do	  not	  
share	  much	  homology	   at	   the	  primary	   sequence	   level,	   they	   are	   structurally	   similar	   in	  
terms	   of	   possessing	   tandem	   repeats	   of	   a	   12	   amino	   acid	   periodicity,	   and	   in	   terms	   of	  
their	   amino	   acid	   composition	   (64%	   and	   66%,	   respectively,	   composed	   of	   the	   amino	  
acids	   proline,	   isoleucine,	   valine,	   aspartate,	   glutamate	   and	   lysine)	   (Al-­‐Khattaf	   et	   al.,	  
2015).	  While	  this	  suggests	  that	  these	  two	  domains	  have	  functionally	  equivalent	  roles,	  
this	  has	  not	  yet	  been	  experimentally	  shown.	  Moreover,	  the	  role	  of	  the	  third	  conserved	  
(non-­‐alveolin)	  ALV3	  domain	  remains	  elusive.	  This	  study	  set	  out	  to	  shed	  light	  on	  these	  
issues	  through	  a	  structure-­‐function	  analysis	  of	  IMC1b.	  	  
The	  first	  experimental	  strategy	  used	  in	  this	  study	  was	  to	  replace	  the	  native	  imc1b	  allele	  
with	  different	  parts	  of	  the	  gene,	  tagged	  with	  GFP,	  in	  a	  ‘knock-­‐in’	  approach.	  This	  would	  
allow	   both	   the	   subcellular	   localisation	   and	   functional	   contribution	   of	   the	   alveolin	  
domains	  to	  SPN	  targeting,	  shape,	  tensile	  strength	  and	  motility	  to	  be	  determined	  in	  live	  
parasites.	   The	   different	   variations	   of	   transgene	   domains	   were	   chosen	   to	   assess	   the	  




function.	   In	  particular	   this	  would	  compare	   the	  contributions	  of	   the	   type	  1	   (ALV1)	  vs.	  
type	  2	   (ALV2)	  alveolin	  domains,	   as	  well	   as	   shed	   light	  on	   the	   role	  of	   the	  non-­‐alveolin	  
(ALV3)	   domain.	   In	   addition,	   IMC1a	   was	   chosen	   to	   be	   expressed	   under	   the	   IMC1b	  
promoter	  in	  order	  to	  test	  the	  hypothesis	  that	  it	  can	  complement	  the	  function	  of	  IMC1b	  
in	  the	  ookinete.	  In	  terms	  of	  experimental	  design,	   it	   is	  possible	  that	  the	  30	  N-­‐terminal	  
amino	   acids	   of	   IMC1b	   upstream	   of	   the	   IMC1b	   domains	   could	   interfere	  with	   correct	  
expression.	  However,	  this	  is	  unlikely	  as	  these	  amino	  acids	  are	  naturally	  present	  in	  full-­‐
length	   IMC1b.	   It	   is	  also	  possible	  that	  the	  C-­‐terminal	  GFP	  module	  could	   interfere	  with	  
the	  function	  of	  the	  upstream	  domains.	  This	  is	  again	  unlikely,	  because	  full-­‐length	  IMC1b	  
can	   be	   GFP-­‐tagged	   without	   apparent	   adverse	   effect	   on	   its	   function	   (Tremp	   et	   al.,	  
2008).	  Nonetheless,	  due	  to	  the	  shorter	  sequences	  of	  the	  domains	  being	  expressed	  and	  
the	  different	  proximity	  of	  the	  N-­‐terminal	  30	  amino	  acids	  and	  C-­‐terminal	  GFP	  module	  to	  
the	  expressed	  domains,	  the	  folding	  of	  the	  fusion	  proteins	  could	  potentially	  be	  affected	  
differently	  compared	  to	  full-­‐length	  IMC1b::GFP.	  	  
Because	  imc1b	  had	  previously	  been	  successfully	  targeted	  for	  tagging	  and	  knockout,	  no	  
problems	  were	  anticipated	  with	  our	  allelic	  replacement	  strategy.	  Initial	  observations	  of	  
the	  uncloned	  parasite	  populations	  using	  confocal	  microscopy	  showed	  positive,	  green	  
fluorescent	   protein	   being	   expressed.	   This	   indicated	   that	   the	   DNA	   constructs	   were	  
accurate	   with	   no	   frame	   shifts,	   with	   exception	   of	   the	   IMC1a	   construct	   as	   was	   later	  
shown.	   However,	   the	   observations	   were	   unexpected	   in	   that	   almost	   every	   green	  
fluorescent	   ookinete	   appeared	   to	   be	   morphologically	   normal	   (Fig.	   3.3B);	   it	   was	  
expected	   that	   at	   least	   some	   of	   the	   allelic	   replacements	   would	   have	   resulted	   in	   an	  




When	  unable	   to	  clone	   the	  desired	   transgenic	  parasites	   from	  second	  and	   third	   round	  
drug	   selected	  populations,	   obtaining	  only	  wildtype	  parasites,	   further	   questions	  were	  
raised	   about	   the	   success	   of	   the	   transfections.	   Indeed,	   genomic	   DNA	   analysis	   of	   the	  
parasites	  from	  second	  and	  third	  rounds	  of	  drug	  selection	  showed	  that	  the	  population	  
of	   parasites	   containing	   an	   integrated	   selectable	  marker	   gene,	   as	  was	   seen	   after	   the	  
first	  round	  of	  drug	  selection,	  decreased	  with	  time.	  This	   indicated	  that	  the	  transgenes	  
were	   in	   fact	   not	   stably	   integrated,	   and	   instead	   were	   being	   expressed	   episomally.	  
Parasites	   with	   episomal	   resistance	   are	   normally	   outgrown	   by	   those	   with	   integrated	  
resistance	   genes,	   because	   only	   part	   of	   the	   progeny	   inherit	   the	   episomes.	   This	   also	  
explained	  why	  only	  clonal	  populations	  with	  unmodified	  imc1b	  alleles	  were	  obtained	  by	  
dilution	  cloning,	  as	  well	  as	  the	  ‘normal’	  shape	  of	  the	  GFP-­‐positive	  ookinetes.	  	  
Besides	   the	   three	   times	   the	   transfections	   were	   repeated	   in	   order	   to	   maximise	   the	  
chances	  of	  pulling	  out	  a	  successfully	  integrated	  transgenic	  parasite,	  an	  effort	  was	  also	  
made	   to	   try	  and	  clone	  out	  parasite	  populations	  directly	   from	   the	   first	   round	  of	  drug	  
selected	   parasites,	   containing	   the	   apparent	   highest	   proportion	   of	   successfully	  
integrated	   DNA	   from	   the	   correct	   size	   fragment	   being	   amplified.	   This	   was	   also	   not	  
fruitful,	   probably	   because	   the	   proportion	   of	   parasites	   with	   episomal	   resistance	   to	  
those	   with	   integrated	   resistance	   was	   too	   high.	   It	   was	   therefore	   not	   justifiable	   to	  
further	  repeat	  dilution	  cloning	  experiments	  as	  it	  was	  wasting	  animal	  units	  needlessly.	  	  
Double	   homologous	   crossover	   recombination	   relies	   on	   two	   separate	   pieces	   of	   DNA	  
having	   large	   stretches	   of	   homologous	   DNA	   sequence.	   During	   replication,	   double-­‐
stranded	  breaks	  are	   formed	   in	   the	  gDNA	  of	   the	  parasite,	  where	  host	  cell	  DNA	  repair	  
mechanisms	  are	  recruited	  to	  repair	   the	  break,	  and	  through	  regions	  of	  high	  sequence	  




integration.	  This	  process	  must	  happen	  at	  both	  the	  5’	  and	  3’	  end	  of	  the	  DNA	  sequence	  
introduced	   in	   order	   for	   successful,	   stable	   integration	   to	   occur.	   On	   balance,	   our	  
collective	   data	   indicate	   that	   no	   stable	   integration	   was	   obtained.	   This	   raises	   two	  
questions.	  First,	  why	  was	  it	  so	  difficult	  to	  achieve	  stable	  integration	  of	  the	  recombinant	  
alleles	   into	  the	   imc1b	   locus,	  given	  that	  this	  had	  worked	  successfully	   in	  the	  past	  using	  
the	   same	   DNA	   construct	   as	   the	   vehicle	   for	   homologous	   recombination?	   Perhaps	  
targeting	  imc1b	  is	  more	  difficult	  than	  was	  originally	  thought.	  There	  could	  also	  be	  small	  
differences	  in	  the	  experimental	  setups	  that	  may	  account	  for	  less	  efficient	  transfection	  
on	  this	  occasion.	  The	  amounts	  of	  residual	  circular	  plasmid	  in	  the	  doubly	  digested	  DNA	  
samples	   used	   for	   transfection	   may	   also	   differ	   (circular	   DNA	   is	   the	   main	   source	   of	  
episomally	  maintained	  resistance),	  although	  extra	  care	  was	  taken	  to	  digest	  the	  DNA	  to	  
completion	   even	   including	   a	   third	   enzyme	   (NotI)	   to	   minimise	   any	   circular	   DNA	  
remaining.	  It	  is	  also	  possible	  that	  the	  successful	  crossover	  events	  into	  the	  imc1b	  locus	  
were	   accompanied	   by	   unforeseen	   recombination	   events	   in	   a	   different	   part	   of	   the	  
genome	  that	  caused	  a	  fitness	  loss	  causing	  these	  parasites	  to	  be	  outcompeted	  by	  those	  
carrying	  episomes.	  	  
The	   second	   question	   raised	   is	   what	   caused	   the	   (false)	   positive	   diagnostic	   PCR	   for	  
integration?	  The	  same	  diagnostic	  PCR	  was	  used	  reliably	   in	  other	  experiments	   (Tremp	  
and	  Dessens,	  2011,	  Tremp	  et	  al.,	  2008),	  suggesting	  it	  is	  a	  good	  diagnostic	  indicator	  of	  
integration.	  It	   is	  possible	  that	  the	  forward	  primer	  may	  have	  annealed	  to	  the	  plasmid-­‐
resident	   tgdhfr	   sequence	   and	   synthesised	   a	   sense	   strand,	   whilst	   the	   reverse	   primer	  
could	  have	  annealed	  to	  the	  genomic	  DNA	  region	  downstream	  of	  the	   integration	  site,	  
and	   produced	   an	   antisense	   strand	   that	   would	   have	   significant	   overlap	   with	   the	  




could	   further	  amplify	   the	  diagnostic	  1.2kb	  DNA	   fragment.	  Whilst	  we	  cannot	   rule	  out	  
this	  possibility,	   it	   is	  worth	  noting	   that	   there	  had	  not	  previously	  been	  any	   issues	  with	  
‘false	  positive’	  diagnostic	  PCR	  in	  the	  Dessens	  laboratory.	  	  
Given	   the	  persistence	  of	   the	  problems	  with	   the	   ‘knock	   in’	   strategy	  used	  here,	   it	  was	  
decided	   to	   change	   to	   the	   second	   approach,	   whereby	   the	   native	   imc1b	   allele	   was	  
replaced	  with	  an	  imc1b	  allele	  lacking	  specific	  modules.	  Using	  this	  strategy,	  only	  1	  in	  12	  
transfections	   led	   to	   verifiable	   stable	   integration,	   indicating	   that	   the	   imc1b	   locus	   is	  
actually	   quite	   difficult	   to	   target.	   In	   the	   one	   experiment	   where	   we	   obtained	   stable	  
integration,	   we	   ended	   up	   with	   a	   population	   that	   contained	   the	   desired	   IMC1bΔ1	  
parasites,	  but	  which	  were	  mixed	  with	  parasites	  encoding	   the	   full-­‐length	   IMC1b::GFP.	  
This	  happens	  when	  crossover	  at	  the	  5’-­‐end	  occurs	  downstream	  of	  the	  mutated	  region.	  
We	  were	  therefore	  unable	  to	  clone	  out	  the	  desired	  parasite	  line.	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Studies	  towards	  resolving	  the	  alveolin	  structure	  
	  
	  





Thirteen	   distinct	   alveolin	   genes	   have	   to	   date	   been	   identified	   in	  Plasmodium	   species	  
(Khater	  et	  al.,	  2004,	  Al-­‐Khattaf	  et	  al.,	  2015,	  Kaneko	  et	  al.,	  2015).	  In	  addition,	  two	  PhIL1	  
interacting	  proteins:	  PIP2	  and	  PIP3,	   show	  structural	  homology	  with	  alveolins	   (Parkyn	  
Schneider	  et	  al.,	  2017,	  Kono	  et	  al.,	  2013),	  and	  these	  could	  represent	  additional	  family	  
members.	   Sequence	   homology	   between	   these	   proteins	   is	   confined	   to	   conserved	  
modules	  named	  ‘alveolin’	  modules	  that	  are	  composed	  of	  tandem	  repeat	  sequences	  of	  
12	   amino	   acid	   periodicity	   (Al-­‐Khattaf	  et	   al.,	   2015).	   Their	   conservation	   and	   structural	  
similarity	  makes	  it	  likely	  that	  these	  ‘alveolin’	  modules	  hold	  the	  physical	  properties	  that	  
facilitate	  the	  putative	  intermediate	  filament	  (IF)-­‐forming	  nature	  of	  the	  alveolins.	  
In	   higher	   eukaryotes,	   IF	   proteins	   such	   as	   lamins,	   vimentins	   and	   α-­‐keratins	   have	   an	  
underlying	   architecture	   that	   includes	   a	   helical	   rod	   domain	   that	   forms	   coiled-­‐coils,	  
which	   is	   thought	  to	  be	  fundamental	   to	  their	   filament-­‐forming	  properties.	  Coiled-­‐coils	  
are	  typically	  formed	  by	  tandem	  repeat	  sequences	  of	  seven	  amino	  acid	  periodicity	  that	  
adopt	  an	  α-­‐helical	  fold.	  The	  interesting	  parallel	  of	  having	  tandem	  repeat	  sequences	  in	  
both	   alveolins	   and	   metazoan	   IF	   proteins	   raises	   the	   possibility	   that	   these	   molecules	  
could	   be	   variations	   on	   the	   same	   theme,	   and	   that	   alveolins	   adopt	   similar	   α-­‐helical	  
configurations	   to	   allow	   filament	   formation,	   despite	   the	   apparent	   differences	   in	  
periodicity.	   Arguing	   against	   this	   concept	   is	   the	   fact	   that	   the	   ‘alveolin’	   modules	   are	  
relatively	  rich	  in	  proline	  residues	  (Al-­‐Khattaf	  et	  al.,	  2015).	  Proline	  is	  a	  cyclic	  and	  bulky	  
residue	  known	  to	  disrupt	  α	  helices	  and	  for	  this	  reason	  this	  amino	  acid	  is	  largely	  absent	  
from	   the	   α-­‐helical	   domains	   of	   metazoan	   IF	   proteins.	   Finally,	   despite	   strong	  
circumstantial	   evidence	   (Mann	   and	   Beckers,	   2001)	   there	   is	   to	   date	   no	   direct	  




Whilst	  alveolins	  have	  been	  characterised	  through	  affinity	  purification	  assays	  (Bullen	  et	  
al.,	   2009),	   they	   have	   yet	   to	   be	   characterised	   for	   their	   structures	   using	   biophysical	  
techniques	   such	   as	   X-­‐ray	   crystallography	   or	   electron	   microscopy.	   As	   alveolins	   are	  
relatively	  uncharacterised	  in	  this	  regard,	  there	  is	  scope	  to	  understand	  how	  the	  protein	  
behaves	   in	  an	  environment	  where	   it	   is	  overexpressed.	  Naturally	  aggregating	  proteins	  
have	   been	   well	   characterised	   before	   for	   their	   structures,	   being	   expressed	   in	   highly	  
denaturing	   conditions	   that	   prevent	   the	   protein	   aggregation	   and	   becoming	   insoluble	  
(Nicolet	  et	  al.,	  2010,	  Herrmann	  and	  Aebi,	  2016).	  	  
To	  address	  some	  of	  these	  questions,	  structural	  data	  of	  the	  alveolins	  was	  set	  out	  to	  be	  
obtained	   through	   a	   programme	   of	   recombinant	   protein	   expression,	   purification	   and	  
ultimately	  structural	  analysis,	  the	  results	  of	  which	  so	  far	  are	  compiled	  in	  this	  chapter.	  




5.2	  Materials	  and	  Methods	  
5.2.2	  Plasmid	  constructs	  	  
To	   generate	   pGEX4T-­‐1	   constructs,	   alveolin	   sequences	   were	   PCR	   amplified	   from	   P.	  
berghei	  genomic	  DNA	  with	  specific	  primer	  pairs	  (Table	  5.1)	  and	  introduced	  into	  BamHI-­‐
digested	  pGEX4T-­‐1	  by	  in-­‐fusion	  cloning.	  	  
To	   generate	   pETM6T1	   constructs,	   alveolin	   sequences	   were	   PCR	   amplified	   from	   P.	  
berghei	   genomic	   DNA	   with	   specific	   primer	   pairs	   (Table	   5.2)	   and	   introduced	   into	  
BamHI/XhoI-­‐digested	  pETM6T1	  by	  in-­‐fusion	  cloning.	  
Table	  5.1.	  PCR	  primer	  sequences	  used	  to	  amplify	  alveolin-­‐specific	  sequences	  for	  cloning	  into	  pGEX4T-­‐1.	  
	  




































Table	  5.2.	  PCR	  primer	  sequences	  used	  to	  amplify	  alveolin-­‐specific	  sequences	  for	  cloning	  into	  pETM6T1.	  

























































A	  glycine-­‐serine	   linker	  between	  the	  TEV	  cleavage	  site	  and	  the	  alveolin	  sequence	  was	  
introduced	  by	  PCR-­‐based	  site	  directed	  mutagenesis	   (see	  Chapter	  2).	  pETM6T1-­‐IMC1e	  
plasmids	   were	   PCR	   amplified	   with	   primers	   SDM	   glycine	   linker-­‐F	  
(AATCTTTATTTTCAGGGTTCGGGTTCGGGTTCGAGCGGTTCGGGCGCCATGGGATCC)	  
and	   SDM	   glycine	   linker-­‐R	   (CTGAAAATAAAGATTCTCACCCGC),	   and	   the	   amplicon	  
circularized	  by	   In-­‐Fusion,	   to	  give	  plasmid	  pETM6T1-­‐NusA-­‐GS-­‐IMC1e.	  This	  changes	  the	  
amino	   acid	   sequence	   from	   …NLYFQ/GAMGS…	   to	   …NLYFQ/GSGSGSSGSGAMGS...	  	  	  	  	  	  	  	  	  	  
(/	  denotes	  TEV	  protease	  cleavage	  junction).	  
5.2.5	  Chromatography	  calibration	  curve	  	  
A	   size	   exclusion	   chromatography	   gel	   calibration	   curve	   was	   made	   by	   running	   using	  




albumin	   (Mr	   66,463),	   chymotrypsinogen	   (Mr	   25,000)	   and	   ribonuclease	  A	   (Mr	   13,700)	  
through	  the	  size	  exclusion	  column.	  The	  Kav	  value	  was	  calculated	  using	   the	  equation:	  
𝐾𝑎𝑣 =      (𝑉𝑒 − 𝑉𝑜)/(𝑉𝑡 − 𝑉𝑜),	  where	  Ve	   is	  equal	   to	   the	  elution	  volume,	  Vo	   is	  equal	  
the	  void	  volume,	  and	  Vt	  is	  equal	  the	  total	  volume	  held	  by	  the	  column.	  The	  void	  volume	  





5.3.1	  Structure	  predictions	  	  
Bioinformatics	   tools	  were	  used	   to	  make	  predictions	  about	   the	   structure	  of	  alveolins.	  
The	  programme	  PrDOS	  was	  used	  to	  look	  at	  the	  disorder	  probability	  of	  the	  alveolins,	  a	  
measure	  of	  the	  conformational	  flexibility	  of	  proteins	  and	  their	  domains.	  This	  revealed	  
that	   the	   conserved	   alveolin	   domains	   are	   predicted	   to	   have	   an	   overall	   ordered	  
structure,	   whilst	   the	   non-­‐conserved	   regions	   upstream	   and	   downstream	   have	  
disordered	  structures,	  as	   is	   illustrated	   for	   IMC1b	   (Fig.	  5.1A).	  Similar	  predictions	  were	  
made	   for	   other	   alveolin	   family	   members	   (data	   not	   shown).	   This	   indicates	   that	   the	  
conserved	  modules	   are	   conformationally	   stable,	  which	   is	   consistent	  with	   the	   notion	  
that	  they	  constitute	  the	  functional	  domains	  of	  the	  protein.	  
The	   programme	   Quick2D	   (MPI	   Bioinformatics	   Toolkit)	   uses	   different	   algorithms	   to	  
make	   secondary	   structure	   predictions	   of	   the	   alveolins.	   As	   illustrated	   for	   IMC1b,	  
alveolin	   domains	   1	   and	   2	   are	   predicted	   to	   have	   a	   predominantly	   β-­‐strand	   structure,	  
whilst	  its	  non-­‐alveolin	  domain	  3	  is	  predicted	  to	  be	  mostly	  α-­‐helical	  (Fig.	  5.1B).	  Similar	  
secondary	  structure	  predictions	  were	  also	  done	  at	  a	   late	  stage	  for	   IMC1e,	   IMC1c	  and	  
IMC1g,	   but	   due	   to	   a	   changed	   algorithm	   repertoire	   used	   by	   Quick2D,	   only	   PSIPRED	  
consistently	  predicted	  β-­‐strand	  fold	  for	  the	  conserved	  domains	  within	  these	  alveolins	  
(Fig.	  5B-­‐E).	  This	  highlights	  the	  unpredictable	  nature	  of	  secondary	  structure	  prediction	  
algorithms.	  Nonetheless,	  these	  findings	  could	  suggest	  that	  the	  alveolin	  modules	  adopt	  
a	  β-­‐pleated	  fold	  rather	  than	  the	  α-­‐helical	  fold.	  
IMC1e,	  IMC1c	  and	  IMC1g	  were	  all	  chosen	  to	  be	  recombinantly	  expressed	  due	  to	  their	  




small	  alveolin	  that	  is	  found	  in	  all	  three	  motile	  zoite	  stages	  of	  the	  malaria	  life	  cycle,	  and	  


























Fig.	  5.1	  (Pages	  80	  -­‐	  82).	  Predictions	  of	  the	  structure	  of	  the	  P.	  berghei	  alveolin	  IMC1b.	  A)	  Protein	  disorder	  prediction	  
using	  PrDOS,	  indicating	  that	  its	  three	  conserved	  domains	  (grey	  blocks)	  (Tremp	  et	  al.,	  2008)	  positively	  correlate	  with	  
conformational	  stability.	  B)	  Secondary	  structure	  predictions	  of	  IMC1b	  using	  Quick2D,	  indicating	  a	  predominantly	  β-­‐
strand	   structure	   (blue	  E)	  of	  domains	  1	  and	  2,	  and	  a	   chiefly	  α-­‐helical	   structure	   (red	  H)	  of	  domain	  3.	  C)	   Secondary	  
structure	  predictions	  of	  IMC1e.	  D)	  Secondary	  structure	  predictions	  of	  IMC1c.	  E)	  Secondary	  structure	  predictions	  of	  
IMC1g.	  The	  domains	  are	  defined	  either	  by	  sequence	  conservation	  (yellow)	  (Tremp	  et	  al.,	  2008),	  or	  by	  the	  presence	  
of	  tandem	  repeat	  structures	  (green)	  (Al-­‐Khattaf	  et	  al.,	  2015).	  
	  
5.3.2	  Recombinant	  protein	  expression	  	  
To	  bacterially	  express	  recombinant	  alveolins,	  or	  alveolin	  domains,	  we	  started	  using	  the	  
pGEX4T	  system.	  This	  system	  expresses	  recombinant	  proteins	  in	  E.	  coli	  as	  fusions	  with	  
glutathione	  S-­‐transferase	  (GST)	  at	  the	  N-­‐terminus.	  Expression	  of	  recombinant	  proteins	  
is	  driven	  by	  the	  IPTG-­‐inducible	  tac	  promoter.	  Subsequently,	  GST	  fusion	  proteins	  can	  be	  
purified	  by	   immobilization	  on	   agarose	  beads	  bound	   to	   reduced	   glutathione,	   and	   the	  
GST	  portion	  can	  be	  cleaved	  with	  thrombin.	  We	  started	  out	  making	  constructs	  for	  GST	  
fusions	  with	   the	  alveolins	   IMC1g	  and	   IMC1c,	  as	  well	  as	   the	  amino	   terminal	  halves	  of	  
IMC1c	  (IMC1c-­‐N)	  and	  IMC1g	  (IMC1g-­‐N)	  that	  contain	  the	  predicted	  ‘alveolin’	  modules.	  
These	  two	  alveolins	  were	  chosen	  as	  they	  are	  the	  smallest	  members	  of	  the	  Plasmodium	  




PCR	  amplification	  of	  the	  various	  parts	  of	  imc1c	  and	  imc1g	  with	  the	  specific	  primer	  pairs	  
(Table	   5.1)	   gave	   rise	   to	   DNA	   fragments	   of	   the	   expected	   sizes	   (Fig.	   5.2A).	   In-­‐Fusion	  
cloning	   of	   these	   fragments	   into	  BamHI-­‐digested	   pGEX4T-­‐1	  was	   verified	   by	   digestion	  
with	  HincII,	   showing	   that	   all	   fragments	  were	   successfully	   cloned	   into	   pGEX4T-­‐1	   (Fig.	  
5.2B).	  Plasmids	  were	  then	  transformed	  into	  E.	  coli	  BL21	  and	  protein	  expression	  in	  small	  
scale	   (10ml)	   cultures	   was	   induced	  with	   100µM	   IPTG	   for	   3	   hours	   at	   37°C.	   SDS-­‐PAGE	  
analysis	   of	   total	   cell	   lysates	   revealed	   that	  GST	   fusions	  with	   the	  N-­‐terminal	   halves	   of	  
IMC1g	  or	  IMC1c	  were	  expressed	  above	  background	  levels,	  giving	  rise	  to	  proteins	  of	  the	  
expected	   sizes	   (45kDa	   GST::IMC1g-­‐N;	   46kDa	   GST::IMC1c-­‐N)	   (Fig.	   5.2C).	   By	   contrast,	  
full-­‐length	  IMC1g	  fused	  to	  GST	  was	  not	  expressed	  at	  discernible	  levels	  (Fig.	  5.2C)	  and	  
the	  same	  was	  true	   for	   full-­‐length	  GST::IMC1c	   (data	  not	  shown).	  However,	  comparing	  
soluble	  and	   insoluble	  cell	   fractions	  revealed	  that	  solubility	  of	  the	  GST	  fusion	  proteins	  







Fig.	  5.2.	  Plasmid	  construction	  and	  alveolin	  protein	  expression	  using	  the	  pGEX4T	  system.	  A)	  PCR	  amplification	  of	  the	  
DNA	   sequences	   encoding	  P.	   berghei	   IMC1c,	   IMC1g,	   and	   the	  N-­‐terminal	   portions	   of	   IMC1c	   (IMC1c-­‐N)	   and	   IMC1g	  
(IMC1g-­‐N)	   using	   specific	   primers	   as	   shown	   in	   Table	   5.1.	   Amplicon	   sizes	   are	   indicated	   on	   the	   right	   hand	   side.	   B)	  
Diagnostic	   digest	  with	  HincII	   shows	   successful	   introduction	  of	   the	  PCR	   fragments	   into	  BamHI-­‐digested	  pGEX4T-­‐1.	  
This	  digest	  gives	  rise	  to	  three	  fragments	  of	  invariable	  length	  (sizes	  indicated	  on	  right	  hand	  side)	  and	  one	  fragment	  of	  
variable	  size	  corresponding	  to	  the	  insert.	  ‘Empty’	  pGEX4T-­‐1	  is	  shown	  as	  the	  reference.	  C)	  Protein	  expression	  of	  the	  
GST::alveolin	  proteins.	  Total	  bacterial	  cell	  lysates	  before	  and	  after	  induction	  with	  100mM	  IPTG	  for	  3h	  at	  37°C	  were	  
fractionated	  by	  SDS-­‐PAGE	  and	  gels	   stained	  with	  Coomassie	  brilliant	  blue.	  The	  position	  of	   the	   recombinant	   fusion	  
proteins	  are	  indicated	  with	  white	  arrows.	  Protein	  molecular	  weight	  markers	  (kDa)	  are	  shown	  and	  sizes	  indicated	  on	  
the	  left	  hand	  side.	  
	  
As	  an	  alternative	  to	  the	  pGEX	  system,	  the	  pETM6T1-­‐based	  bacterial	  expression	  system	  
was	   used.	   The	   latter	   allows	   expression	   of	   recombinant	   proteins	   as	   carboxy-­‐terminal	  
fusions	   to	   N-­‐utilisation	   substance	   protein	   A	   (NusA),	   a	   fusion	   tag	   that	   is	   well	  
documented	  to	  confer	  stability	  and	  increases	  solubility	  of	  its	  bound	  protein	  (De	  Marco	  
et	   al.,	   2004,	   Dummler	   et	   al.,	   2005,	   Turner	   et	   al.,	   2005).	   The	   pET	   system	   drives	  
expression	   from	   the	   bacteriophage	   T7	   promoter	   by	   an	   IPTG-­‐inducible	   T7	   RNA	  
polymerase	  that	   is	  encoded	  by	  the	  bacterial	  host.	  The	  NusA	  tag	  contains	  a	  6×His	   tag	  
and	   a	   TEV	   protease	   cleavage	   site,	   to	   release	   and	   remove	   the	   tag	   from	   the	   fusion	  
protein	   after	   expression.	   For	   this	   expression	   system,	   we	   also	   included	   the	   central	  




alveolin	  population	  as	  a	  whole	  and	  thus	  arguably	  most	  representative	  of	  the	  family	  (Al-­‐
Khattaf	  et	  al.,	  2015).	  The	  conserved	  alveolin	  domains	  from	  IMC1e,	  IMC1c	  and	  IMC1g,	  
as	  well	  as	  the	  entire	  IMC1c	  and	  IMC1g	  proteins,	  were	  successfully	  PCR	  amplified	  from	  
P.	  berghei	   genomic	  DNA	   (Fig.	  5.3A,	  not	   shown	   for	   IMC1e)	  using	   specific	  primer	  pairs	  
(Table	   5.2).	   The	   resulting	   fragments	   were	   successfully	   introduced	   into	   BamHI/XhoI	  
digested	   pETM6T1	   as	   determined	   by	   diagnostic	   digests	   with	   EcoRV	   (Fig.	   5.3B).	   The	  
resulting	  plasmids	  were	   transformed	   into	  E.	   coli	   BL21(DE3).	   Initial	   expression	   studies	  
were	  carried	  out	  on	  small	  scale	  cultures	  induced	  with	  100µM	  IPTG	  for	  3	  hours	  at	  37°C.	  	  
This	   resulted	   in	   considerably	   higher	   expression	   levels	   of	   the	   expected	   recombinant	  
fusion	   proteins	   than	   was	   observed	   in	   the	   pGEX	   system	   (Fig.	   5.3C).	   Furthermore,	  
comparing	   soluble	   and	   insoluble	   cell	   fractions	   revealed	   that	   solubility	   of	   the	   NusA	  
fusion	   proteins	  was	  much	   high	   under	   the	   expression	   conditions	   used	   (at	   least	   50%)	  
(Fig.	   5.3D).	   Due	   to	   this	   superior	   performance	   of	   the	   pETM6T1	   system,	   all	   ensuing	  






Fig.	  5.3.	  Plasmid	  construction	  and	  alveolin	  protein	  expression	  using	  the	  pETM6T1	  system.	  A)	  PCR	  amplification	  of	  
the	  DNA	  sequences	  encoding	  P.	  berghei	  IMC1c,	  IMC1g,	  and	  the	  N-­‐terminal	  portions	  of	  IMC1c	  (IMC1c-­‐N)	  and	  IMC1g	  
(IMC1g-­‐N)	   using	   specific	   primers	   as	   shown	   in	   Table	   5.2.	   Amplicon	   sizes	   are	   indicated	   on	   the	   right	   hand	   side.	   B)	  
Diagnostic	  digest	  with	  EcoRV	  shows	  successful	  introduction	  of	  the	  PCR	  fragments	  into	  BamHI/XhoI-­‐digested	  pET6T1.	  
This	   digest	   gives	   rise	   to	   two	   fragments	   of	   invariable	   length	   (2.5	   and	   0.5kb)	   and	   one	   fragment	   of	   variable	   size	  
corresponding	   to	   the	   insert	   (sizes	   indicated	   on	   right	   hand	   side).	   ‘Empty’	   pETM6T1	   is	   shown	   as	   the	   reference.	   C)	  
Protein	  expression	  of	  the	  NusA::alveolin	  proteins.	  Total	  bacterial	  cell	  lysates	  before	  and	  after	  induction	  with	  100mM	  
IPTG	   for	   4h	   at	   37°C	   were	   fractionated	   by	   SDS-­‐PAGE	   and	   gels	   stained	   with	   Coomassie	   brilliant	   blue.	   Protein	  
molecular	   weight	   markers	   (kDa)	   are	   shown	   and	   sizes	   indicated	   on	   the	   left	   hand	   side.	   D)	   Equivalent	   soluble	   vs	  
insoluble	  fractions	  of	  bacterial	  lysates	  after	  IPTG	  induction.	  Protein	  molecular	  weight	  markers	  (kDa)	  are	  shown	  and	  






5.3.2	  Purification	  of	  IMC1c-­‐N	  	  
After	  small	   scale	  cultures	  determined	  that	   the	  NusA	  expression	  system	  was	  efficient,	  
large	   scale	   cultures	  were	  used	   to	   increase	   recombinant	   protein	   yields.	   This	  was	   first	  
carried	  out	  with	  IMC1c-­‐N,	  which	  corresponds	  to	  one	  of	  the	  smaller	  alveolin	  domains.	  
After	   recombinant	  protein	  expression,	  bacterial	  cells	  were	   lysed	  and	  ultracentrifuged	  
to	  remove	  insoluble	  material.	  The	  lysate	  was	  then	  incubated	  with	  TALON	  metal	  affinity	  
resin	   (i.e.	   cobalt	   ions	   immobilized	   on	   agarose	   beads)	   binding	   the	   recombinant	  
NusA::alveolin	   fusion	   protein	   (via	   its	   6×His-­‐tag)	   and	   allowing	   non-­‐target	   bacterial	  
proteins	  to	  be	  washed	  away.	  The	  part-­‐purified	  NusA::alveolin	  fusion	  protein	  was	  then	  
eluted	  off	   the	   TALON	  batch	   column	  with	   imidazole-­‐containing	   buffer,	   and	   incubated	  
with	  TEV	  protease	   to	  cleave	  off	   the	  NusA	   tag.	  The	   latter	   step	  was	  carried	  out	  at	  4°C	  
overnight,	   whilst	   dialysing	   to	   remove	   excess	   imidazole	   from	   the	   solution.	   In	   this	  
experiment,	  the	  TEV	  protease	  efficiently	  cleaved	  the	  fusion	  protein	   into	   its	   individual	  
NusA	  and	  IMC1c-­‐N	  components	  (Fig.	  5.4A).	  	  
The	   cleaved	   solution	   was	   further	   fractionated	   on	   a	   size	   exclusion	   column,	   with	   the	  
majority	  of	  the	  alveolin	  protein	  eluting	  in	  fractions	  15-­‐17	  (Fig.	  5.4A).	  Unexpectedly,	  the	  
latter	   protein	   partially	   co-­‐eluted	  with	   the	  much	   larger	  NusA	   protein	   (Fig.	   5.4A).	   This	  
observation	  suggested	  that	  the	  alveolin	  domain	  was	  not	  behaving	  as	  a	  globular	  protein	  
and	  therefore	  eluted	  earlier	  than	  expected,	  together	  with	  the	  globular	  NusA	  protein.	  	  
Fractions	  15-­‐17	  were	  pooled,	  and	   the	  alveolin	  protein	  was	  successfully	  purified	   from	  
the	  NusA	  protein	  using	  a	  HiTrap	  Q	  ion	  exchange	  column:	  a	  pure	  alveolin	  fraction	  was	  
present	   in	   the	   HiTrap	   Q	   wash	   through,	   while	   NusA	   and	   other	   proteins	   eluted	   as	  




To	  further	  purify	  and	  concentrate	  the	  IMC1c-­‐N	  protein,	  another	  size	  exclusion	  column	  
was	  used.	  Unexpectedly,	  the	  protein	  did	  not	  elute	   in	  a	  fraction	  expected	  for	  a	  20kDa	  
protein,	   instead	  eluting	   in	   fractions	  16-­‐18,	  much	  closer	   to	   the	  void	   (Fig.	  5.4C).	  A	   size	  
exclusion	   chromatography	   gel	   calibration	   curve	   was	   made	   to	   determine	   what	  
molecular	  weight	  protein	  would	  be	  eluted	  in	  fractions	  16-­‐18	  (Fig.	  5.4D).	  This	  indicated	  
that	   these	   fractions	   should	   contain	   protein	   of	   molecular	   weight	   closer	   to	   80kDa,	  
suggesting	  that	  the	  IMC1c-­‐N	  protein	  could	  be	  forming	  tetramers.	  	  
	  
Fig.	   5.4.	   Purification	   of	   bacterially	   expressed	   IMC1c-­‐N.	   A)	   Coomassie-­‐stained	   protein	   gel	   showing	   efficient	   TEV	  
protease	  cleavage	  of	  NusA::IMC1c-­‐N	  fusion	  protein	  (lane	  marked	  Before	  TEV,	  white	  arrow)	  into	  NusA	  and	  IMC1c-­‐N	  
(lane	  marked	  After	  TEV,	  white	  arrows).	  Other	   lanes	  marked	  Fraction	  9	   -­‐	   Fraction	  21	   show	  elution	  of	   the	  alveolin	  
portion	   in	   Fractions	   15-­‐17	   from	  a	   size	   exclusion	   column.	   Protein	  molecular	  weight	  markers	   (kDa)	   are	   shown	  and	  
sizes	  indicated	  on	  the	  left	  hand	  side.	  B)	  Coomassie-­‐stained	  protein	  gel	  showing	  the	  presence	  of	  the	  IMC1c-­‐N	  in	  the	  
wash	  through	  of	  a	  HiTrap	  Q	  anion	  exchange	  column	  (lane	  marked	  Wash	  through).	  NusA	  elutes	  as	  conductivity	  of	  the	  
column	  increases	  (lanes	  marked	  Fraction	  44	  –	  Fraction	  63).	  Protein	  molecular	  weight	  markers	  (kDa)	  are	  shown	  and	  
sizes	  indicated	  on	  the	  left	  hand	  side.	  C)	  Chromatogram	  of	  a	  size	  exclusion	  column	  showing	  that	  the	  IMC1c-­‐N	  protein	  
elutes	   in	   fractions	   16-­‐18.	   D)	   Size	   exclusion	   chromatography	   calibration	   curve	   made	   using	   Chymotrypsinogen,	  





To	  further	  concentrate	  the	  protein	  for	  downstream	  analysis,	  the	  protein	  solution	  was	  
centrifuged	   through	   a	   protein	   concentrator	   with	   a	   10kDa	   molecular	   weight	   cut-­‐off.	  
During	  this	  process,	  the	  protein	  became	  insoluble	  and	  precipitated	  at	  a	  concentration	  
of	  approximately	  2.5mg/mL.	  The	  amount	  of	  protein	  left	  in	  solution	  was	  approximately	  
0.22mg/mL,	  but	  this	  was	  too	  low	  to	  conduct	  further	  downstream	  structural	  analyses.	  
Subsequent	   repeats	   of	   these	   protocols	   using	   construct	   IMC1c-­‐N	   failed	   to	   reproduce	  
the	   results.	   Specifically,	   in	   these	   repeat	   experiments	   the	   target	   protein	   already	  
precipitated	  during	  the	  TEV	  protease	  cleavage	  step.	  	  
5.3.4	  Purification	  of	  IMC1e	  	  
Given	   the	   problems	   encountered	   with	   IMC1c-­‐N,	   we	   switched	   our	   attention	   to	  
construct	   pETM6T1-­‐IMC1e,	   expressing	  NusA	   fused	   to	   the	   alveolin	   domain	   of	   IMC1e.	  
IMC1e	   is	   structurally	  most	   similar	   to	   the	  Plasmodium	   alveolin	   family,	  but	   its	   alveolin	  
domain	  is	   larger	  than	  that	  of	   IMC1c	  (Al-­‐Khattaf	  et	  al.,	  2015).	  The	  NusA::IMC1e	  fusion	  
protein	  was	  successfully	  expressed	  in	   large	  scale	  culture	  and	  partly	  purified	  using	  the	  
TALON	   metal	   affinity	   resin	   (Fig.	   5.5A).	   However,	   in	   contrast	   to	   NusA::IMC1c-­‐N,	   the	  
NusA::IMC1e	   fusion	   protein	   was	   poorly	   cleaved	   with	   the	   TEV	   protease	   and	   no	  
discernible	  cleavage	  product	  corresponding	  to	  the	  alveolin	  portion	  was	  detected	  (Fig.	  
5.5A).	  
TEV	  protease	  cleavage	  is	  generally	  very	  efficient.	  One	  possible	  explanation	  for	  the	  poor	  
cleavage	  efficiency	  on	  this	  occasion	  was	  that	  the	  IMC1e	  domain	  was	  too	  close	  to	  the	  
TEV	  cleavage	  site	  and	  its	  specific	  folding	  might	  prevent	  access	  to	  the	  cleavage	  site	  by	  
the	  TEV	  protease.	   In	   this	   context,	   it	   is	  noteworthy	   that	   the	  NusA::IMC1c-­‐N	  construct	  
contains	  some	  20	  amino	  acids	  corresponding	  to	  the	  IMC1c	  amino	  terminus	  in	  between	  




al.,	   2014).	   For	   this	   reason	   a	   10	   amino	   acid	   glycine-­‐serine	   linker	   was	   introduced	  
immediately	   downstream	   of	   the	   TEV	   cleavage	   site	   in	   the	   NusA::IMC1e-­‐encoding	  
pETM6T1	  plasmid	  (resulting	  in	  plasmid	  pETM6T1-­‐NusA-­‐GS-­‐IMC1e).	  	  
The	  modified	  NusA::IMC1e	   fusion	   protein	  was	   again	   successfully	   expressed	   and	   part	  
purified	   on	   TALON	   resin	   (Fig.	   5.5B).	   Overnight	   TEV	   protease	   treatment	   in	   solution	  
resulted	   in	  complete	   loss	  of	   the	   fusion	  protein	  and	   the	  concurrent	  appearance	  of	   its	  
cleavage	   products	   corresponding	   to	   NusA	   and	   the	   IMC1e	   alveolin	   portion.	   This	  
indicated	   that	   the	   addition	   of	   the	   glycine-­‐serine	   linker	   between	   the	   TEV	   protease	  
cleavage	   site	   and	   the	   alveolin	   domain	   had	   indeed	   made	   the	   cleavage	   site	   better	  
accessible	   to	   the	   protease.	   The	   IMC1e	   portion	   migrated	   at	   a	   position	   smaller	   than	  
expected	   of	   its	   calculated	   mass	   (32kDa).	   In	   contrast	   to	   off-­‐column	   cleavage,	   TEV	  
protease	  cleavage	  on	  the	  column	  (i.e.	   in	  the	  presence	  of	  the	  TALON	  resin)	  was	  much	  
less	  efficient	  and	  only	  resulted	  in	  partial	  cleavage	  (Fig.	  5.5B).	  In	  fact,	  the	  latter	  was	  also	  
observed	  for	  on	  the	  column	  cleavage	  of	  the	  NusA::IMC1c-­‐N	  protein	  (data	  not	  shown).	  
Efforts	  to	  further	  purify	  and	  concentrate	  the	  recombinant	  IMC1e	  alveolin	  domain	  are	  
ongoing.	  However,	  these	  efforts	  are	  being	  hindered	  by	  protein	  precipitation	  during	  the	  
TEV	   protease	   cleavage	   step,	   similar	   to	   what	   was	   observed	   with	   the	   NusA::IMC1c-­‐N	  








Fig.	   5.5.	   Purification	   of	   bacterially	   expressed	   IMC1e.	   A)	   Coomassie-­‐stained	   protein	   gel	   showing	   bacterial	  
NusA::IMC1e	   expression	   (lane	  marked	   Total,	   white	   arrow),	   solubility	   (lane	  marked	   Soluble),	   part	   purification	   on	  
TALON	  resin	  (lanes	  marked	  Eluates	  1-­‐5),	  but	  inefficient	  TEV	  protease	  cleavage	  (lane	  marked	  TEV	  cleavage).	  Protein	  
molecular	  weight	  markers	  (kDa)	  are	  shown	  and	  sizes	  indicated	  on	  the	  left	  hand	  side.	  B)	  Coomassie-­‐stained	  protein	  
gel	   showing	   efficient	   expression	   and	   TALON	   purification	   of	   NusA::IMC1e	  with	   glycine-­‐serine	   linker	   (lane	  marked	  
Before	  TEV	  cleavage),	  and	  efficient	  TEV	  protease	  cleavage	  in	  solution	  (lanes	  marked	  After	  TEV	  cleavage	  off-­‐column).	  
Black	  arrows	  mark	  positions	  of	  the	  fusion	  protein	  and	  cleavage	  products.	   	  The	  TEV	  protease	  cleavage	  is	  much	  less	  
efficient	  on	  the	  column	  (lanes	  marked	  After	  TEV	  cleavage	  on-­‐column).	  A	  sample	  of	  the	  TEV	  protease	  is	  also	  shown	  
(lane	  marked	  TEV	  enzyme).	  Protein	  molecular	  weight	  markers	  (kDa)	  are	  shown	  and	  sizes	  indicated	  on	  the	  left	  hand	  
side.	  
	  





Secondary	   structure	   predictions	   (Fig.	   5.1)	   suggest	   that	   the	   Plasmodium	   alveolin	  
domains	   are	   conformationally	   stable	   and	   adopt	   a	   β-­‐pleated	   structure.	   Indeed,	   the	  
latter	  is	  corroborated	  by	  a	  recent	  study	  predicting	  that	  alveolins	  and	  related	  epiplastin	  
proteins	  across	  different	  radiations	  adopt	  an	  overall	  β-­‐strand	  fold	  (Goodenough	  et	  al.,	  
2018).	   Although	   not	   common,	   there	   are	   examples	   where	   β-­‐strands	   are	   involved	   in	  
filament	  formation,	  most	  notable	  members	  of	  the	  β-­‐keratin	  family	  in	  birds	  and	  reptiles	  
(Fraser	   and	   Parry,	   2009).	   In	   these	   proteins,	   dimers	   are	   assembled	   via	   interactions	  
between	   short	   β-­‐sheet	   domains	  within	  monomers	   that	   are	   rich	   in	   valine,	   isoleucine	  
and	  proline	  residues.	  These	  protofilaments	  polymerase	  to	  form	  long	  filaments	  3-­‐4nm	  
in	   diameter	   that	   possess	   viscoelastic	   properties	   and	   are	   detergent-­‐insoluble	   (Fraser	  
and	  Parry,	  2009).	  It	  is	  compelling	  that	  many	  of	  these	  features	  are	  shared	  with	  alveolins	  
and	   it	   is	   tempting	   to	   speculate	   that	   alveolins	   could	   form	   filaments	   through	  a	   similar	  
mechanism.	   However,	   this	   can	   only	   be	   confirmed	   using	   biophysical	   techniques.	   For	  
example,	   size	   exclusion	   chromatography	   with	   multiple	   angle	   light	   scattering	   (SEC-­‐
MALS)	  will	  generate	  data	  on	  the	  exact	  molecular	  weight	  of	  the	  protein	  in	  question	  and	  
whether	   it	   forms	   oligomers	   of	   any	   kind	   with	   itself.	   Circular	   dichroism	   spectroscopy	  
(CDS)	  will	  give	  an	  insight	  into	  whether	  the	  protein	  solution	  contains	  mainly	  α-­‐helices	  or	  
β-­‐strands.	  X-­‐ray	  crystallography	  or	  electron	  microscopy	  can	  be	  applied	  to	  shed	  light	  on	  
the	  3D	  atomic	  structure	  of	  the	  protein	  under	  investigation.	  	  
To	   facilitate	   such	   structural	   biological	   studies,	   a	   program	   of	   recombinant	   alveolin	  
expression	   and	   purification	   was	   embarked	   on.	   Expression	   and	   purification	   of	  
recombinant	  proteins	  are	  two	  important	  and	  vital	  aspects	  of	  protein	  structural	  biology	  




bacteria	  can	  have	  detrimental	  effects	  and	  lead	  to	  toxic	  build-­‐up	  of	  proteins	  within	  the	  
cell	   that	  may	   interrupt	   vital	   cellular	   processes.	   Some	   proteins	   need	   very	   specific	   pH	  
and	   temperatures	   for	   expression	   and	   can	   only	   be	   expressed	   in	   low	   amounts	   before	  
aggregating	   within	   the	   cell.	   Some	   proteins	   need	   extensive	   post-­‐translational	  
modifications	   that	  make	  bacterial	   cell	   cultures	  unsuitable,	  and	   there	  are	  many	  other	  
conditions	  that	  may	  need	  to	  be	  met	   in	  order	  to	  ensure	  a	  protein	   is	  stable	  enough	  to	  
extract	  from	  a	  cell.	  Purification	  presents	  other	  challenges,	  for	  example	  with	  respect	  to	  
protein	  stability	  and	  solubility.	  	  
The	   results	   presented	   in	   this	   chapter	   show	   that	   the	   bacterial	   expression	   system,	   as	  
well	   as	   the	   conditions	   for	   TEV	   protease	   cleavage,	   were	   successfully	   optimised.	  
Expression	   of	   the	   alveolins	   with	   an	   N-­‐terminal	   NusA	   tag	   clearly	   works	   much	   better	  
than	   a	   GST	   tag	   both	   in	   terms	   as	   expression	   level	   and	   solubility.	   Moreover,	   TEV	  
protease	   cleavage	   works	   much	   better	   in	   solution	   than	   it	   does	   on	   the	   column.	   The	  
results	   furthermore	  show	  that	   the	  alveolin	  domain	  must	  not	  be	  too	  close	  to	  the	  TEV	  
protease	  recognition	  sequence	  as	  it	  could	  prevent	  protease	  access	  to	  the	  cleavage	  site.	  
Despite	   these	   considerable	   advances,	   the	   project	   has	   so	   far	   fallen	   short	   of	   purifying	  
sufficiently	   large	   amounts	   of	   recombinant	   alveolin	   protein	   to	   conduct	   the	   planned	  
downstream	   structural	   analyses.	   One	   of	   the	   main	   problems	   encountered	   was	   the	  
protein	   precipitating	   during	   the	   TEV	   protease	   cleavage	   step.	   The	   removal	   of	   the	  
imidazole	  during	  TEV	  protease	  treatment	  is	  itself	  unlikely	  to	  initiate	  precipitation	  of	  the	  
protein,	  which	  indicates	  that	  it	  is	  the	  release	  of	  the	  NusA	  tag	  from	  the	  alveolin	  portion	  
that	   is	   causing	   loss	   of	   solubility.	  On	  other	   occasions,	   the	   protein	   precipitated	  during	  
concentration,	   suggesting	   that	   alveolin	   solubility	   may	   also	   be	   linked	   to	   its	  




module	   is	   not	   globular,	   and	   has	   a	   tendency	   to	   oligomerise.	   The	   latter	   may	   be	   an	  
underlying	  feature	  of	  the	  alveolins,	  and	  perhaps	  the	  degree	  of	  polymerisation	  is	  linked	  
to	  their	  solubility.	  Such	  properties	  are	  not	  incompatible	  with	  IF	  forming	  proteins,	  and	  
in	  fact	  could	  be	  fundamentally	  linked	  to	  the	  ability	  of	  alveolins	  in	  the	  cell	  to	  assemble	  
into	   the	   filamentous	   SPN	   structure,	   which	   is	   notoriously	   insoluble	   and	   detergent-­‐






































Alongside	  microtubules	  and	  actin	  filaments,	  intermediate	  filaments	  (IFs)	  constitute	  one	  
of	   the	   three	   main	   cytoskeletal	   systems	   in	   eukaryotic	   cells.	   Often	   referred	   to	   as	  
‘membrane	  skeletons’,	  IF	  networks	  provide	  viscoelastic	  support	  to	  membranes	  and	  as	  
such	   are	   essential	   in	   maintaining	   cell	   integrity,	   shape	   and	   function.	   In	   contrast	   to	  
animals	   and	   amoeba	   that	   have	   actin/spectrin-­‐based	   plasma	   membrane	   skeletons,	  
apicomplexan	   parasites	   possess	   a	   unique	   actin/spectrin-­‐free	   membrane	   skeleton	  
known	  as	  the	  SPN.	  The	  SPN	  is	  part	  of	  a	  unique	  structure	  known	  as	  the	  pellicle,	  which	  is	  
found	   predominantly	   in	   the	   invasive	   and	   motile	   life	   cycle	   stages	   (zoites)	   of	   these	  
parasites.	  The	  pellicle	   is	  defined	  by	  a	  double	  membrane	   layer	  named	  the	   IMC	  that	   is	  
located	  directly	  underneath	  the	  plasma	  membrane.	  This	  IMC	  is	  equivalent	  to	  a	  system	  
of	   single-­‐membrane,	   flattened	   sacs	   known	   as	   alveoli,	   which	   are	   a	   unifying	  
morphological	   feature	   that	   link	   the	   Apicomplexa	   with	   dinoflagellates	   and	   ciliates	  
within	  the	  Alveolata	  superphylum.	  The	  SPN	  is	  situated	  on	  the	  cytoplasmic	  side	  of	  the	  
IMC,	   with	   which	   it	   is	   tightly	   associated,	   forming	   an	   internal	   cytoskeletal	   basket	  
supporting	   the	   IMC	  membranes	   and	  providing	  both	   rigidity	   and	   flexibility	   to	   the	   cell	  
(Mann	  and	  Beckers,	  2001).	  	  
Over	   a	   decade	   ago,	   a	   novel	   family	   of	   IMC1	   proteins,	   now	   named	   alveolins,	   were	  
reported	  to	  be	  major	  components	  of	  the	  SPN	  in	  Plasmodium	  and	  related	  apicomplexan	  
parasites	  (Khater	  et	  al.,	  2004).	  Members	  of	  the	  alveolin	  protein	  family	  are	  also	  found	  in	  
other	   alveolates	   (Gould	  et	  al.,	   2008)	   and	  are	  part	  of	   a	   larger	   class	  of	  proteins	   called	  
epiplastins	  that	  have	  also	  been	  identified	  in	  euglenids,	  glaucophytes	  and	  cryptophytes	  
(Goodenough	   et	   al.,	   2018).	   In	   the	   genus	   Plasmodium,	   13	   conserved	   and	   syntenic	  




three	   different	   zoite	   stages	   of	   malaria	   parasites:	   the	   merozoite,	   ookinete	   and	  
sporozoite	   (Al-­‐Khattaf	   et	   al.,	   2015;	   Kaneko	   et	   al.,	   2015).	   It	   has	   been	   shown	   in	   the	  
malaria	   species	  P.	  berghei	   that	  disruption	  of	   the	  alveolins	   IMC1a,	   IMC1b,	   IMC1h	  and	  
IMC1i	  gives	  rise	  to	  morphological	  aberrations	  accompanied	  by	  reduced	  tensile	  strength	  
of	   the	   zoite	   stages	   in	   which	   they	   are	   expressed	   (Kaneko	   et	   al.,	   2015;	   Khater	   et	   al.,	  
2004;	  Tremp	  and	  Dessens,	  2011;	  Tremp	  et	  al.,	  2008;	  Volkmann	  et	  al.,	  2012),	  identifying	  
roles	  in	  morphogenesis	  and	  viscoelasticity.	  In	  addition,	  null	  mutant	  parasites	  of	  IMC1a,	  
IMC1b	   and	   IMC1h	   were	   shown	   to	   display	   reduced	   and	   abnormal	   motility,	  
demonstrating	  that	  at	  least	  a	  subset	  of	  alveolins	  also	  participate	  in	  parasite	  locomotion	  
via	  a	  hitherto	  poorly	  understood	  mechanism	  (Khater	  et	  al.,	  2004;	  Tremp	  and	  Dessens,	  
2011;	  Tremp	  et	  al.,	  2008;	  Volkmann	  et	  al.,	  2012).	  Simultaneous	  knockout	  of	  IMC1h	  and	  
IMC1b	  severely	  reduces	  ookinete	  motility	   (Tremp	  and	  Dessens,	  2011),	   indicating	  that	  
these	   two	   alveolins	   in	   particular	   are	  main	   players	   in	   alveolin-­‐facilitated	   locomotion.	  
The	  combined	   impacts	  on	  zoite	   shape,	   tensile	   strength	  and	  motility	   result	   in	  marked	  
reductions	   in	   infectivity	   of	   alveolin	   null	   mutant	   parasites,	   leading	   to	   inability	   to	  
complete	  the	   life	  cycle	   (Kaneko	  et	  al.,	  2015;	  Khater	  et	  al.,	  2004;	  Tremp	  and	  Dessens,	  
2011;	   Tremp	   et	   al.,	   2008;	   Volkmann	   et	   al.,	   2012).	   Studies	   in	   the	   related	   parasite	  
Toxoplasma	   gondii	   have	   identified	   14	   distinct	   alveolin	   species	   also	   localising	  
predominantly	  in	  the	  SPN,	  with	  some	  having	  additional	  roles	  in	  cell	  division	  (Anderson-­‐
White	   et	   al.,	   2011;	   Dubey	   et	   al.,	   2017).	   This	   collective	  work	   indicates	   that	   alveolins	  
occupy	  stage-­‐	  and	  development-­‐specific	  functional	  niches	  across	  the	  entire	  life	  cycle	  of	  
apicomplexan	  parasites.	  	  
In	   this	   thesis,	   a	   body	   of	   work	   is	   presented	   that	   significantly	   advances	   our	  




provided	  that	  the	  ‘alveolin’	  module	  is	  the	  domain	  responsible	  for	  targeting	  the	  alveolin	  
IMC1h	   to	   the	   SPN	   (Chapter	   4).	   This	   is	   likely	   to	   also	   be	   the	   case	   for	   other	   alveolins,	  
because	  the	   ‘alveolin’	  domain	   is	  shared	  between	  all	  alveolin	  species.	  Evidence	   is	  also	  
provided	   that	   the	   IMC1h-­‐specific	   ‘non-­‐alveolin’	   domain	   (domain	   2)	   of	   IMC1h	   has	   a	  
likely	   role	   in	   ookinete	   and	   sporozoite	   motility	   (Chapter	   4).	   This	   data	   supports	   the	  
hypothesis	  that	   IMC1h	  facilitates	  motility	  by	   interacting,	  through	   its	  carboxy-­‐terminal	  
domain,	  with	  components	  of	  the	  motility	  apparatus	  directly,	  or	  indirectly	  via	  bridging	  
proteins	  in	  the	  IMC.	  Indeed,	  the	  same	  could	  apply	  to	  the	  ookinete-­‐expressed	  alveolin	  
IMC1b,	  and	  to	  the	  sporozoite-­‐expressed	  alveolin	  IMC1a,	  each	  of	  which	  also	  have	  roles	  
in	  motility	  and	  possess	  a	  carboxy-­‐terminal	  conserved	  ‘non-­‐alveolin’	  domain	  (domain	  3)	  
(Khater	  et	  al.,	  2004;	  Tremp	  and	  Dessens,	  2011;	  Tremp	  et	  al.,	  2008).	  Indeed,	  in	  Chapter	  
3,	   attempts	   were	   made	   to	   address	   this	   question	   for	   IMC1b.	   Unexpectedly,	   many	  
problems	   were	   encountered	   with	   achieving	   stable	   integration	   of	   the	   recombinant	  
modified	  imc1b	  allelles	  into	  the	  target	  locus.	  The	  most	  likely	  reason	  for	  these	  problems	  
is	  that	  the	   imc1b	   locus	   is	  more	  difficult	  to	  target	  by	  homologous	  recombination	  than	  
was	  previously	   thought.	  However,	   it	  may	  be	  worth	  revisiting	  this	   topic,	  especially	  via	  
the	   ‘domain	   knockout’	   strategy	   that	   worked	   so	   well	   for	   IMC1h,	   in	   an	   approach	  
designed	  to	  maximize	  stable	  integration,	  for	  example	  by	  using	  higher	  amounts	  of	  DNA	  
and/or	   schizonts	   during	   transfections.	   If	   successful,	   it	   would	   be	   interesting	   to	   see	   if	  
IMC1b	  behaves	  like	  IMC1h	  in	  such	  a	  structure-­‐function	  analysis	   in	  live	  ookinetes,	  and	  
the	  results	  could	  add	  further	  insights	  into	  the	  question	  of	  how	  alveolins	  contribute	  to	  
zoite	  locomotion.	  Other	  future	  studies	  to	  shed	  light	  on	  this	  question	  would	  be	  to	  carry	  
out	   comparative	   IMC1h	   interactome	   studies	  using	  parasite	   lines	   IMC1hΔ2,	   IMC1hΔ1,	  
IMC1h/GFP	   and	   IMC1h-­‐KO	   ookinetes,	   which	   would	   allow	   the	   identification	   of	  




availability	   of	   the	  GFP-­‐tagged	  parasite	   lines	   generated	  would	   allow	  GFP	  pulldown	  of	  
IMC1b	   protein	   complexes	   followed	   by	   quantitative	   mass	   spectrometry	   to	   identify	  
individual	   protein	   constituents.	   This	   approach	   has	   been	   successfully	   used	   in	   the	  
Dessens	   lab	   to	   characterize	  protein	   complexes	  of	   the	  ookinete-­‐expressed	  LCCL	   lectin	  
adhesive-­‐like	  proteins	  (LAPs)	  (Tremp	  et	  al.,	  2017).	  
Our	  understanding	  of	  alveolin	   function	  and	  mode	  of	  action	   in	   the	  parasite	  would	  be	  
greatly	  enhanced	  if	  we	  possessed	  information	  on	  their	  structure,	   in	  particular	  that	  of	  
the	   core	   ‘alveolin’	   module	   that	   is	   a	   shared	   feature	   of	   the	   protein	   family.	   Structural	  
information	   on	   these	   molecules	   could	   also	   be	   helpful	   to	   inform	   which	   compound	  
might	  be	  able	  to	  interfere	  with	  alveolin	  assembly	  and/or	  function,	  for	  example	  through	  
in	   silico	   screening	   platforms.	   For	   this	   reason,	   studies	   presented	   in	   Chapter	   5	   were	  
focussed	   on	   the	   recombinant	   expression	   and	   purification	   of	   these	   molecules.	   A	  
combination	   of	   different	   downstream	   biophysical	   analyses	   would	   then	   allow	   us	   to	  
determine	  if	  the	  proteins	  oligomerise	  or	  form	  filaments,	  as	  well	  as	  their	  core	  secondary	  
structures	  (e.g.	  α-­‐helix,	  β-­‐strand)	  and	  even	  high	  resolution	  3D	  structures.	  
	  Our	   initial	  bioinformatic	  analyses	  predicted	   that	   the	  conserved	  alveolin	  domains	  are	  
structured,	   and	   further	   pointed	   to	   a	   predominantly	   β-­‐strand	   rather	   than	   α-­‐helical	  
secondary	  structure	  associated	  with	  the	  core	  ‘alveolin’	  modules.	  This	   is	  supported	  by	  
the	   fact	   that	   these	   sequences	   are	   abundant	   in	   proline	   residues,	   which	   is	   poorly	  
compatible	  with	  α-­‐helices.	  A	  suitable	  bacterial	  expression	  system	  was	  then	   identified	  
based	  on	  the	  N-­‐terminal	  fusion	  of	  the	  alveolin	  proteins	  with	  the	  NusA	  protein	  tag.	  This	  
system	   allows	   high	   expression	   levels	   and	   solubility	   of	   the	   fusion	   proteins.	   The	  NusA	  
portion	   can	   be	   removed	   from	   the	   target	   alveolin	   portions	   by	   cleavage	   with	   TEV	  




the	  column.	  Furthermore,	  it	  is	  important	  that	  the	  TEV	  protease	  cleavage	  site	  is	  not	  too	  
close	  to	  the	  alveolin	  domain,	  for	  risk	  of	  the	  site	  being	  prevented	  from	  protease	  access.	  	  
Unfortunately,	   we	   were	   so	   far	   unable	   to	   purify	   sufficiently	   large	   amounts	   of	   the	  
recombinant	   alveolin	   proteins	   to	   carry	   out	   structural	   analyses.	   The	   main	   problem	  
appears	  to	  be	  poor	  solubility	  of	  the	  alveolin	  once	  the	  NusA	  tag	  is	  removed,	  resulting	  in	  
the	   protein	   precipitating	   out	   of	   solution.	   The	   same	   happens	   when	   the	   protein	   is	  
concentrated	   to	   levels	   suitable	   for	   biophysical	   analyses.	   Whilst	   this	   has	   prevented	  
meaningful	   structural	   analyses,	   these	   observations	  may	   nonetheless	   be	   giving	   some	  
important	   clues	   about	   the	   physical	   properties	   of	   alveolins.	   For	   example,	   a	  
concentration-­‐dependent	   solubility	   could	   reflect	   the	   way	   by	   which	   these	   molecules	  
assemble	   in	   the	   cell	   into	   the	   insoluble	   SPN	   structure,	   possibly	   via	   the	   intermittent	  
formation	  of	  shorter	  oligomers	  (protofilaments).	  
Due	  to	  the	  uncharacterised	  alveolins	  ability	  to	  become	  insoluble	  and	  precipitate	  during	  
these	  experiments,	  harsher	  denaturing	  conditions	  could	  circumvent	  this.	  Experiments	  
using	   guanidine	   and	   urea	   in	   protein	   purification	   buffers	   denature	   the	   protein	   in	  
question.	  The	  denatured	  protein	  is	  then	  able	  to	  be	  purified	  using,	  for	  example,	  a	  6×His	  
tag,	  whereby	  high	  concentrations	  of	  protein	  can	  be	  achieved.	  The	  protein	  is	  then	  able	  
to	  be	  refolded	  using	  protein	  folding	  co-­‐solvents,	  providing	  a	  solution	  to	  the	  problems	  
encountered	  during	  this	  project	  (Wingfield,	  2001).	  	  	  
Optimisation	  of	  buffers	  and	  protocols	  provide	  promising	  next	  steps	  for	  the	  purification	  
of	  the	  alveolins,	  as	  well	  as	  using	  different	  protein	  tags	  that	  are	  perhaps	  small	  enough	  
not	  to	  have	  to	  be	  cleaved,	  whilst	  at	  the	  same	  time	  maintaining	  solubility	  of	  the	  fusion	  
proteins.	  We	   could	   also	   try	   to	   express	   different	   alveolin	   domains,	   a	   strategy	   which	  




that	  in	  some	  experiments	  NusA	  cleavage	  was	  achieved	  without	  precipitation,	  and	  this	  
would	  be	  a	  useful	  starting	  point	  for	  optimising	  steps	  to	  further	  purify	  and	  concentrate	  
the	  cleaved	  alveolin	  proteins.	  
6.2	  Future	  Work	  
The	  experiments	  conducted	  throughout	  this	  project	  allowed	  for	  further	  understanding	  
of	  how	   the	   individual	  alveolin	  domains	   contribute	   to	   the	  proteins	   function,	  and	  how	  
the	  protein	  behaves	  when	  expressed	  and	  purified	   from	  bacterial	  expression	  systems.	  
IMC1h	   was	   characterised	   during	   this	   project	   and	   provided	   an	   insight	   in	   to	   how	   its	  
alveolin	   domain	   contributes	   to	   the	   localisation	   of	   the	   protein	   to	   the	   subpellicular	  
network.	  However,	  the	  question	  of	  how	  alveolin	  type	  1	  and	  type	  2	  domains	  contribute	  
to	   the	   proteins	   function	   in	   the	   subpellicular	   network	   remains	   unanswered.	   It	   also	  
remains	  unanswered	  if	  alveolins	  are	  able	  to	  form	  autofilaments	  with	  one	  another,	  or	  if	  
filament-­‐forming	   properties	   are	   restricted	   to	   each	   individual	   alveolin.	   Future	  
experiments	   to	   investigate	   functional	   differences	   between	   between	   alveolin	   type	   1	  
and	   type	   2	   domains,	   for	   example	   by	   structure-­‐function	   analysis	   of	   IMC1b,	   would	  
address	  these	  questions.	  	  
Substantial	  work	  has	  been	  done	  to	  study	  bacterial	  expression	  of	  the	  alveolins	  IMC1e,	  
IMC1c	   and	   IMC1g.	  One	  way	   forward	   is	   to	   investigate	   the	  use	  of	   strongly	   denaturing	  
conditions	   to	   purify	   the	   protein,	   and	   re-­‐fold	   it	   using	   protein	   folding	   co-­‐solvents.	  
Another	   strategy	   going	   forward	   would	   be	   to	   utilise	   the	   Plasmodium	   itself	   to	   purify	  
protein	  from.	  As	  Plasmodium	  berghei	  allows	  for	  large	  scale	  ookinete	  culturing,	  a	  large	  
amount	  of	  alveolin	  protein	  could	  potentially	  be	  obtained	  from	  transgenic	  parasite	  lines	  
by	  affinity	  purification.	  Alternatively,	  the	  mosquito	  stage-­‐specific	  alveolin	  genes	  could	  




stage	  parasites	  and	  potentially	   large	  amounts	  of	  material	   to	  be	  harvested.	  Using,	   for	  
example,	  GFP	  pulldown	  assays,	  alveolins	  could	  be	  purified	  directly	   from	  the	  parasite,	  
avoiding	  the	  need	  to	  express	  and	  purify	  protein	  from	  bacterial	  expression	  systems,	  and	  
harvesting	  the	  material	  from	  a	  more	  physiologically	  relevant	  environment.	  This	  would	  
potentially	  circumvent	  the	  problem	  of	  the	  protein	  precipitating	  during	  the	  purification	  
process.	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